| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.801 | 0.003 | 0.883 | Alcohol oxidase inhibitor | 0.883 0.002 DBMET01476 0.862 0.002 DBMET01477 0.359 0.004 DBMET00137 | DBMET01476 | |
| 0.77 | 0.002 | 0.828 | Alpha-N-acetylglucosaminidase inhibitor | 0.828 0.002 DBMET01476 0.809 0.002 DBMET01477 0.652 0.003 DBMET00137 | DBMET01476 | |
| 0.727 | 0.005 | 0.864 | Platelet antagonist | 0.562 0.009 DBMET01476 0.864 0.004 DBMET01477 | DBMET01477 | |
| 0.701 | 0.005 | 0.701 | Hypolipemic | 0.524 0.011 DBMET01477 | ||
| 0.7 | 0.008 | 0.73 | Aldehyde oxidase inhibitor | 0.584 0.021 DBMET01476 0.73 0.006 DBMET01477 0.57 0.023 DBMET00137 | DBMET01477 | |
| 0.656 | 0.019 | 0.765 | Cyclophilin D inhibitor | 0.26 0.202 DBMET01476 0.765 0.009 DBMET01477 | DBMET01477 | |
| 0.638 | 0.002 | 0.858 | GABA C receptor agonist | 0.733 0.002 DBMET01476 0.858 0.001 DBMET01477 0.526 0.003 DBMET00137 | DBMET01477 | |
| 0.631 | 0.015 | 0.674 | Cholesterol antagonist | 0.525 0.029 DBMET01476 0.674 0.01 DBMET01477 0.333 0.072 DBMET00137 | DBMET01477 | |
| 0.642 | 0.031 | 0.736 | Caspase 9 stimulant | 0.493 0.062 DBMET01476 0.736 0.02 DBMET01477 0.468 0.074 DBMET00137 | DBMET01477 | |
| 0.614 | 0.014 | 0.621 | Vasodilator, peripheral | 0.361 0.069 DBMET01476 0.621 0.014 DBMET01477 0.27 0.113 DBMET00137 | DBMET01477 | |
| 0.594 | 0.012 | 0.594 | 5 Hydroxytryptamine release inhibitor | 0.407 0.074 DBMET01476 0.583 0.013 DBMET01477 0.496 0.034 DBMET00137 | ||
| 0.581 | 0.003 | 0.778 | Succinate dehydrogenase inhibitor | 0.778 0.002 DBMET01476 0.704 0.002 DBMET01477 0.317 0.008 DBMET00137 | DBMET01476 | |
| 0.547 | 0.017 | 0.617 | Histamine release inhibitor | 0.462 0.044 DBMET01476 0.617 0.009 DBMET01477 0.411 0.07 DBMET00137 | DBMET01477 | |
| 0.54 | 0.012 | 0.59 | Hypoglycemic | 0.346 0.039 DBMET01476 0.59 0.009 DBMET01477 | DBMET01477 | |
| 0.523 | 0.002 | 0.64 | Triose-phosphate isomerase inhibitor | 0.64 0.002 DBMET01476 0.625 0.002 DBMET01477 0.296 0.005 DBMET00137 | DBMET01476 | |
| 0.521 | 0.008 | 0.649 | Platelet aggregation inhibitor | 0.649 0.005 DBMET01477 | DBMET01477 | |
| 0.516 | 0.012 | 0.549 | Superoxide dismutase inhibitor | 0.549 0.009 DBMET01476 0.539 0.01 DBMET01477 0.378 0.031 DBMET00137 | DBMET01476 | |
| 0.522 | 0.02 | 0.614 | GABA C receptor rho-3 antagonist | 0.443 0.044 DBMET01476 0.591 0.008 DBMET01477 0.614 0.006 DBMET00137 | DBMET00137 | |
| 0.503 | 0.005 | 0.575 | Insulin secretagoues | 0.155 0.07 DBMET01476 0.575 0.004 DBMET01477 | DBMET01477 | |
| 0.506 | 0.009 | 0.588 | Peroxidase inhibitor | 0.39 0.022 DBMET01476 0.588 0.005 DBMET01477 0.481 0.011 DBMET00137 | DBMET01477 | |
| 0.51 | 0.022 | 0.51 | Immunomodulator | 0.448 0.032 DBMET01477 | ||
| 0.506 | 0.02 | 0.657 | Apoptosis antagonist | 0.622 0.008 DBMET01476 0.657 0.005 DBMET01477 | DBMET01477 | |
| 0.489 | 0.004 | 0.7 | Aldehyde dehydrogenase inhibitor | 0.7 0.003 DBMET01476 0.413 0.005 DBMET01477 0.162 0.041 DBMET00137 | DBMET01476 | |
| 0.513 | 0.029 | 0.513 | Immunosuppressant | 0.46 0.044 DBMET01476 0.509 0.031 DBMET01477 | ||
| 0.473 | 0.003 | 0.561 | Carbamoyl phosphate synthetase inhibitor | 0.41 0.003 DBMET01476 0.561 0.002 DBMET01477 0.212 0.007 DBMET00137 | DBMET01477 | |
| 0.482 | 0.018 | 0.482 | Vasodilator, coronary | 0.258 0.127 DBMET01476 0.374 0.045 DBMET01477 0.278 0.107 DBMET00137 | ||
| 0.476 | 0.013 | 0.525 | Angiogenesis stimulant | 0.321 0.042 DBMET01476 0.525 0.01 DBMET01477 | DBMET01477 | |
| 0.468 | 0.01 | 0.512 | Anesthetic general | 0.309 0.031 DBMET01476 0.512 0.007 DBMET01477 0.256 0.048 DBMET00137 | DBMET01477 | |
| 0.466 | 0.014 | 0.466 | Psychostimulant | 0.256 0.056 DBMET01476 0.426 0.019 DBMET01477 0.149 0.117 DBMET00137 | ||
| 0.462 | 0.013 | 0.548 | Interleukin 2 agonist | 0.408 0.025 DBMET01476 0.548 0.005 DBMET01477 | DBMET01477 | |
| 0.525 | 0.078 | 0.589 | Antiinflammatory | 0.415 0.13 DBMET01476 0.589 0.057 DBMET01477 | DBMET01477 | |
| 0.451 | 0.007 | 0.561 | 5 Hydroxytryptamine uptake stimulant | 0.426 0.01 DBMET01476 0.561 0.003 DBMET01477 0.427 0.01 DBMET00137 | DBMET01477 | |
| 0.426 | 0.009 | 0.487 | Phospholipase C inhibitor | 0.289 0.019 DBMET01476 0.487 0.006 DBMET01477 0.193 0.049 DBMET00137 | DBMET01477 | |
| 0.413 | 0.007 | 0.651 | Tyrosine 3 hydroxylase inhibitor | 0.438 0.005 DBMET01476 0.651 0.003 DBMET01477 0.394 0.009 DBMET00137 | DBMET01477 | |
| 0.444 | 0.039 | 0.547 | Antithrombotic | 0.519 0.027 DBMET01476 0.547 0.023 DBMET01477 0.215 0.159 DBMET00137 | DBMET01477 | |
| 0.407 | 0.004 | 0.796 | Porphobilinogen synthase inhibitor | 0.652 0.003 DBMET01476 0.796 0.002 DBMET01477 0.287 0.005 DBMET00137 | DBMET01477 | |
| 0.416 | 0.02 | 0.434 | DNA synthesis inhibitor | 0.424 0.019 DBMET01476 0.434 0.018 DBMET01477 0.287 0.048 DBMET00137 | DBMET01477 | |
| 0.417 | 0.02 | 0.417 | Vasodilator | 0.385 0.026 DBMET01477 | ||
| 0.406 | 0.018 | 0.479 | Interleukin agonist | 0.319 0.039 DBMET01476 0.479 0.01 DBMET01477 0.288 0.054 DBMET00137 | DBMET01477 | |
| 0.417 | 0.045 | 0.417 | Immunostimulant | 0.379 0.056 DBMET01476 0.402 0.049 DBMET01477 0.173 0.137 DBMET00137 | ||
| 0.375 | 0.004 | 0.491 | Phosphofructokinase-1 inhibitor | 0.491 0.002 DBMET01476 0.48 0.002 DBMET01477 0.218 0.009 DBMET00137 | DBMET01476 | |
| 0.375 | 0.004 | 0.603 | Ferrochelatase inhibitor | 0.452 0.003 DBMET01476 0.603 0.002 DBMET01477 0.398 0.004 DBMET00137 | DBMET01477 | |
| 0.414 | 0.043 | 0.547 | 5 Hydroxytryptamine release stimulant | 0.248 0.09 DBMET01476 0.547 0.02 DBMET01477 0.537 0.022 DBMET00137 | DBMET01477 | |
| 0.39 | 0.02 | 0.474 | Sodium/bile acid cotransporter inhibitor | 0.395 0.018 DBMET01476 0.474 0.005 DBMET01477 | DBMET01477 | |
| 0.397 | 0.029 | 0.397 | DNA damaging | 0.338 0.044 DBMET01477 | ||
| 0.362 | 0.004 | 0.429 | Adenylate kinase inhibitor | 0.429 0.003 DBMET01476 0.425 0.003 DBMET01477 0.277 0.008 DBMET00137 | DBMET01476 | |
| 0.364 | 0.008 | 0.398 | Gastrin inhibitor | 0.307 0.028 DBMET01476 0.398 0.005 DBMET01477 0.275 0.053 DBMET00137 | DBMET01477 | |
| 0.366 | 0.01 | 0.366 | Protein kinase stimulant | 0.194 0.044 DBMET01476 0.337 0.013 DBMET01477 0.151 0.068 DBMET00137 | ||
| 0.362 | 0.012 | 0.399 | Bone formation stimulant | 0.26 0.023 DBMET01476 0.399 0.01 DBMET01477 | DBMET01477 | |
| 0.355 | 0.004 | 0.507 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.352 0.004 DBMET01476 0.507 0.002 DBMET01477 0.273 0.008 DBMET00137 | DBMET01477 | |
| 0.364 | 0.017 | 0.39 | Platelet adhesion inhibitor | 0.271 0.043 DBMET01476 0.39 0.013 DBMET01477 | DBMET01477 | |
| 0.35 | 0.005 | 0.493 | Catalase inhibitor | 0.493 0.002 DBMET01476 0.411 0.004 DBMET01477 0.167 0.022 DBMET00137 | DBMET01476 | |
| 0.356 | 0.022 | 0.574 | Growth hormone agonist | 0.396 0.016 DBMET01476 0.574 0.004 DBMET01477 | DBMET01477 | |
| 0.341 | 0.008 | 0.351 | UDP-glucose 4-epimerase inhibitor | 0.351 0.008 DBMET01476 0.331 0.009 DBMET01477 0.335 0.009 DBMET00137 | DBMET01476 | |
| 0.35 | 0.019 | 0.35 | Hepatoprotectant | 0.262 0.04 DBMET01476 0.347 0.019 DBMET01477 | ||
| 0.368 | 0.039 | 0.396 | Calcium channel activator | 0.274 0.119 DBMET01476 0.396 0.026 DBMET01477 0.38 0.033 DBMET00137 | DBMET01477 | |
| 0.391 | 0.064 | 0.535 | Toll-Like receptor agonist | 0.535 0.026 DBMET01477 | DBMET01477 | |
| 0.373 | 0.046 | 0.373 | Spasmolytic | 0.337 0.057 DBMET01477 | ||
| 0.368 | 0.042 | 0.387 | Antioxidant | 0.296 0.063 DBMET01476 0.387 0.037 DBMET01477 | DBMET01477 | |
| 0.329 | 0.003 | 0.752 | Glutamate decarboxylase inhibitor | 0.752 0.002 DBMET01476 0.734 0.002 DBMET01477 0.178 0.009 DBMET00137 | DBMET01476 | |
| 0.334 | 0.015 | 0.358 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.244 0.045 DBMET01476 0.358 0.011 DBMET01477 0.269 0.034 DBMET00137 | DBMET01477 | |
| 0.322 | 0.005 | 0.641 | Glutamate dehydrogenase inhibitor | 0.445 0.004 DBMET01476 0.641 0.002 DBMET01477 0.19 0.011 DBMET00137 | DBMET01477 | |
| 0.321 | 0.004 | 0.321 | Ornithine carbamoyltransferase inhibitor | 0.269 0.005 DBMET01476 0.26 0.005 DBMET01477 0.11 0.014 DBMET00137 | ||
| 0.412 | 0.108 | 0.412 | Apoptosis agonist | 0.363 0.132 DBMET01477 | ||
| 0.305 | 0.005 | 0.359 | Alcohol dehydrogenase inhibitor | 0.339 0.005 DBMET01476 0.359 0.004 DBMET01477 0.108 0.044 DBMET00137 | DBMET01477 | |
| 0.318 | 0.018 | 0.41 | Lipocortins synthesis antagonist | 0.282 0.025 DBMET01476 0.41 0.008 DBMET01477 | DBMET01477 | |
| 0.311 | 0.017 | 0.542 | Amylase inhibitor | 0.542 0.005 DBMET01476 0.349 0.013 DBMET01477 0.188 0.048 DBMET00137 | DBMET01476 | |
| 0.296 | 0.004 | 0.334 | Photosensitizer | 0.233 0.008 DBMET01476 0.334 0.004 DBMET01477 0.155 0.028 DBMET00137 | DBMET01477 | |
| 0.304 | 0.013 | 0.304 | Phospholipase A2 inhibitor | 0.298 0.014 DBMET01476 0.302 0.013 DBMET01477 | ||
| 0.293 | 0.002 | 0.293 | GABA B receptor agonist | 0.147 0.004 DBMET01476 0.271 0.003 DBMET01477 0.101 0.016 DBMET00137 | ||
| 0.311 | 0.021 | 0.311 | Peptidyltransferase inhibitor | 0.22 0.076 DBMET01476 0.31 0.021 DBMET01477 | ||
| 0.395 | 0.105 | 0.536 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.385 0.115 DBMET01476 0.469 0.05 DBMET01477 0.536 0.02 DBMET00137 | DBMET00137 | |
| 0.309 | 0.021 | 0.311 | Diuretic | 0.311 0.021 DBMET01477 | DBMET01477 | |
| 0.303 | 0.015 | 0.321 | Insulin sensitizer | 0.233 0.045 DBMET01476 0.321 0.012 DBMET01477 0.173 0.104 DBMET00137 | DBMET01477 | |
| 0.3 | 0.013 | 0.3 | Alkylator | 0.193 0.028 DBMET01476 0.241 0.018 DBMET01477 0.108 0.08 DBMET00137 | ||
| 0.326 | 0.044 | 0.408 | Insulysin inhibitor | 0.347 0.035 DBMET01476 0.408 0.021 DBMET01477 0.297 0.06 DBMET00137 | DBMET01477 | |
| 0.283 | 0.002 | 0.698 | Aconitate hydratase inhibitor | 0.345 0.002 DBMET01476 0.698 0.001 DBMET01477 0.155 0.004 DBMET00137 | DBMET01477 | |
| 0.288 | 0.007 | 0.288 | Farnesoid X receptor antagonist | 0.231 0.014 DBMET01477 | ||
| 0.31 | 0.03 | 0.367 | RNA-directed DNA polymerase inhibitor | 0.244 0.053 DBMET01476 0.367 0.022 DBMET01477 0.299 0.032 DBMET00137 | DBMET01477 | |
| 0.358 | 0.078 | 0.508 | Toll-Like receptor 7 agonist | 0.508 0.03 DBMET01477 | DBMET01477 | |
| 0.294 | 0.02 | 0.294 | Neurotrophic factor enhancer | 0.208 0.069 DBMET01476 0.294 0.02 DBMET01477 0.233 0.049 DBMET00137 | ||
| 0.297 | 0.024 | 0.46 | Thrombolytic | 0.262 0.031 DBMET01476 0.46 0.007 DBMET01477 | DBMET01477 | |
| 0.272 | 0.004 | 0.411 | Phenylalanine 4-hydroxylase inhibitor | 0.205 0.006 DBMET01476 0.411 0.003 DBMET01477 0.156 0.011 DBMET00137 | DBMET01477 | |
| 0.286 | 0.022 | 0.336 | Interferon gamma antagonist | 0.233 0.032 DBMET01476 0.336 0.015 DBMET01477 0.186 0.047 DBMET00137 | DBMET01477 | |
| 0.269 | 0.007 | 0.355 | NADH dehydrogenase inhibitor | 0.19 0.011 DBMET01476 0.355 0.005 DBMET01477 0.251 0.008 DBMET00137 | DBMET01477 | |
| 0.272 | 0.014 | 0.315 | Chelator | 0.315 0.01 DBMET01477 | DBMET01477 | |
| 0.353 | 0.1 | 0.451 | Antibacterial | 0.451 0.057 DBMET01476 0.36 0.096 DBMET01477 | DBMET01476 | |
| 0.256 | 0.005 | 0.301 | Creatine kinase inhibitor | 0.178 0.015 DBMET01476 0.301 0.004 DBMET01477 0.214 0.009 DBMET00137 | DBMET01477 | |
| 0.256 | 0.005 | 0.256 | Vanilloid 1 agonist | 0.153 0.035 DBMET01476 0.207 0.01 DBMET01477 0.137 0.054 DBMET00137 | ||
| 0.283 | 0.032 | 0.354 | Non-steroidal antiinflammatory agent | 0.288 0.031 DBMET01476 0.354 0.019 DBMET01477 | DBMET01477 | |
| 0.331 | 0.083 | 0.373 | Transcription factor NF kappa B inhibitor | 0.338 0.081 DBMET01476 0.373 0.07 DBMET01477 0.188 0.181 DBMET00137 | DBMET01477 | |
| 0.253 | 0.005 | 0.259 | Arachidonic acid antagonist | 0.233 0.01 DBMET01476 0.259 0.004 DBMET01477 0.219 0.018 DBMET00137 | DBMET01477 | |
| 0.299 | 0.052 | 0.343 | Free radical scavenger | 0.16 0.133 DBMET01476 0.343 0.04 DBMET01477 | DBMET01477 | |
| 0.259 | 0.014 | 0.277 | Cell wall synthesis inhibitor | 0.183 0.038 DBMET01476 0.277 0.012 DBMET01477 0.165 0.051 DBMET00137 | DBMET01477 | |
| 0.255 | 0.012 | 0.298 | Expectorant | 0.179 0.025 DBMET01476 0.298 0.009 DBMET01477 0.116 0.054 DBMET00137 | DBMET01477 | |
| 0.248 | 0.007 | 0.273 | Mucolytic | 0.185 0.017 DBMET01476 0.273 0.005 DBMET01477 0.145 0.036 DBMET00137 | DBMET01477 | |
| 0.249 | 0.009 | 0.265 | Toll-Like receptor 2 antagonist | 0.214 0.018 DBMET01476 0.265 0.007 DBMET01477 0.158 0.047 DBMET00137 | DBMET01477 | |
| 0.285 | 0.048 | 0.302 | Cyclic AMP phosphodiesterase inhibitor | 0.302 0.041 DBMET01477 0.202 0.092 DBMET00137 | DBMET01477 | |
| 0.242 | 0.014 | 0.28 | Aminopeptidase B inhibitor | 0.263 0.012 DBMET01476 0.28 0.01 DBMET01477 0.181 0.026 DBMET00137 | DBMET01477 | |
| 0.233 | 0.008 | 0.353 | GABA C receptor antagonist | 0.195 0.014 DBMET01476 0.353 0.004 DBMET01477 0.257 0.006 DBMET00137 | DBMET01477 | |
| 0.236 | 0.011 | 0.278 | Carbonic anhydrase III inhibitor | 0.138 0.034 DBMET01476 0.278 0.007 DBMET01477 0.129 0.039 DBMET00137 | DBMET01477 | |
| 0.229 | 0.005 | 0.268 | Adenylate cyclase stimulant | 0.204 0.012 DBMET01476 0.268 0.004 DBMET01477 0.195 0.016 DBMET00137 | DBMET01477 | |
| 0.221 | 0.005 | 0.221 | Interferon agonist | 0.122 0.017 DBMET01476 0.17 0.008 DBMET01477 0.09 0.038 DBMET00137 | ||
| 0.22 | 0.005 | 0.374 | Biliverdin reductase inhibitor | 0.242 0.004 DBMET01476 0.374 0.002 DBMET01477 0.208 0.005 DBMET00137 | DBMET01477 | |
| 0.233 | 0.018 | 0.344 | Cystathionine beta-synthase inhibitor | 0.208 0.023 DBMET01476 0.344 0.007 DBMET01477 0.226 0.019 DBMET00137 | DBMET01477 | |
| 0.23 | 0.017 | 0.23 | Neurotrophic factor | 0.137 0.072 DBMET01476 0.138 0.071 DBMET01477 | ||
| 0.247 | 0.034 | 0.294 | Nitric-oxide synthase stimulant | 0.201 0.087 DBMET01476 0.276 0.019 DBMET01477 0.294 0.013 DBMET00137 | DBMET00137 | |
| 0.216 | 0.003 | 0.22 | Ca2+-transporting ATPase inhibitor | 0.19 0.004 DBMET01476 0.22 0.002 DBMET01477 0.192 0.004 DBMET00137 | DBMET01477 | |
| 0.222 | 0.01 | 0.269 | Uric acid excretion stimulant | 0.269 0.005 DBMET01476 0.252 0.007 DBMET01477 | DBMET01476 | |
| 0.232 | 0.02 | 0.318 | Cholesterol synthesis inhibitor | 0.318 0.01 DBMET01476 0.295 0.012 DBMET01477 0.14 0.05 DBMET00137 | DBMET01476 | |
| 0.22 | 0.01 | 0.22 | Selectin antagonist | 0.088 0.033 DBMET01476 0.212 0.01 DBMET01477 | ||
| 0.217 | 0.01 | 0.217 | MAP3K9 inhibitor | |||
| 0.226 | 0.018 | 0.273 | GABA C receptor rho-2 antagonist | 0.176 0.045 DBMET01476 0.27 0.008 DBMET01477 0.273 0.008 DBMET00137 | DBMET00137 | |
| 0.21 | 0.004 | 0.246 | Glycine receptor agonist | 0.157 0.006 DBMET01476 0.246 0.003 DBMET01477 0.128 0.011 DBMET00137 | DBMET01477 | |
| 0.207 | 0.001 | 0.27 | Glucose-6-phosphate isomerase inhibitor | 0.27 0.001 DBMET01476 0.256 0.001 DBMET01477 0.117 0.004 DBMET00137 | DBMET01476 | |
| 0.223 | 0.017 | 0.223 | Interleukin 4 antagonist | 0.115 0.093 DBMET01476 0.176 0.032 DBMET01477 | ||
| 0.219 | 0.013 | 0.219 | Cyclooxygenase 3 inhibitor | 0.146 0.052 DBMET01476 0.219 0.013 DBMET01477 0.157 0.042 DBMET00137 | ||
| 0.21 | 0.006 | 0.21 | Vanilloid agonist | 0.123 0.017 DBMET01477 | ||
| 0.234 | 0.03 | 0.234 | Antipruritic | 0.218 0.038 DBMET01477 | ||
| 0.223 | 0.019 | 0.542 | Cell adhesion inhibitor | 0.147 0.049 DBMET01476 0.542 0.004 DBMET01477 | DBMET01477 | |
| 0.215 | 0.013 | 0.215 | Mediator release inhibitor | 0.181 0.018 DBMET01477 | ||
| 0.206 | 0.005 | 0.239 | Acyl-CoA dehydrogenase inhibitor | 0.172 0.007 DBMET01476 0.239 0.003 DBMET01477 0.192 0.006 DBMET00137 | DBMET01477 | |
| 0.203 | 0.003 | 0.203 | Estrogen-related receptor beta agonist | 0.11 0.015 DBMET01476 0.15 0.004 DBMET01477 0.114 0.013 DBMET00137 | ||
| 0.231 | 0.031 | 0.231 | Lipid peroxidase inhibitor | 0.224 0.033 DBMET01477 | ||
| 0.258 | 0.059 | 0.531 | Interleukin antagonist | 0.207 0.08 DBMET01476 0.531 0.017 DBMET01477 | DBMET01477 | |
| 0.328 | 0.134 | 0.406 | Calcium channel L-type activator | 0.406 0.077 DBMET01477 | DBMET01477 | |
| 0.217 | 0.025 | 0.221 | ATPase inhibitor | 0.189 0.048 DBMET01476 0.221 0.023 DBMET01477 0.18 0.058 DBMET00137 | DBMET01477 | |
| 0.228 | 0.037 | 0.378 | Protein-tyrosine phosphatase inhibitor | 0.169 0.063 DBMET01476 0.378 0.01 DBMET01477 | DBMET01477 | |
| 0.199 | 0.008 | 0.223 | Keratolytic | 0.103 0.029 DBMET01476 0.223 0.007 DBMET01477 0.108 0.026 DBMET00137 | DBMET01477 | |
| 0.194 | 0.004 | 0.22 | Sphingosine 1-phosphate receptor 4 agonist | 0.145 0.009 DBMET01476 0.22 0.004 DBMET01477 0.088 0.031 DBMET00137 | DBMET01477 | |
| 0.202 | 0.013 | 0.372 | Histidine decarboxylase inhibitor | 0.219 0.011 DBMET01476 0.372 0.004 DBMET01477 0.189 0.014 DBMET00137 | DBMET01477 | |
| 0.199 | 0.012 | 0.204 | Sphingosine 1-phosphate receptor 5 antagonist | 0.144 0.071 DBMET01476 0.204 0.01 DBMET01477 0.169 0.034 DBMET00137 | DBMET01477 | |
| 0.194 | 0.008 | 0.376 | Argininosuccinate synthase inhibitor | 0.376 0.003 DBMET01476 0.354 0.003 DBMET01477 0.171 0.01 DBMET00137 | DBMET01476 | |
| 0.194 | 0.009 | 0.28 | GABA C receptor rho-1 antagonist | 0.17 0.014 DBMET01476 0.28 0.004 DBMET01477 0.223 0.005 DBMET00137 | DBMET01477 | |
| 0.194 | 0.009 | 0.321 | Electrolyte absorption antagonist | 0.197 0.008 DBMET01476 0.321 0.004 DBMET01477 0.174 0.012 DBMET00137 | DBMET01477 | |
| 0.271 | 0.086 | 0.292 | Lipoxygenase inhibitor | 0.279 0.082 DBMET01476 0.292 0.075 DBMET01477 | DBMET01477 | |
| 0.187 | 0.003 | 0.64 | Fumarate hydratase inhibitor | 0.311 0.003 DBMET01476 0.64 0.001 DBMET01477 0.094 0.006 DBMET00137 | DBMET01477 | |
| 0.209 | 0.026 | 0.429 | Catenin beta inhibitor | 0.222 0.019 DBMET01476 0.429 0.004 DBMET01477 | DBMET01477 | |
| 0.203 | 0.021 | 0.203 | Antibacterial (Helicobacter pylori) | 0.158 0.04 DBMET01477 | ||
| 0.195 | 0.014 | 0.229 | Carbonic anhydrase VI inhibitor | 0.097 0.041 DBMET01476 0.229 0.01 DBMET01477 0.095 0.042 DBMET00137 | DBMET01477 | |
| 0.189 | 0.008 | 0.252 | Aminopeptidase I inhibitor | 0.174 0.009 DBMET01476 0.252 0.004 DBMET01477 0.14 0.014 DBMET00137 | DBMET01477 | |
| 0.194 | 0.013 | 0.194 | Gastric antisecretory | 0.148 0.027 DBMET01477 | ||
| 0.199 | 0.02 | 0.199 | Microtubule formation inhibitor | 0.166 0.03 DBMET01476 0.197 0.02 DBMET01477 0.144 0.041 DBMET00137 | ||
| 0.187 | 0.009 | 0.238 | DOPA decarboxylase inhibitor | 0.185 0.009 DBMET01476 0.238 0.004 DBMET01477 0.177 0.011 DBMET00137 | DBMET01477 | |
| 0.189 | 0.011 | 0.208 | Sphingosine 1-phosphate receptor 2 antagonist | 0.145 0.047 DBMET01476 0.208 0.006 DBMET01477 0.155 0.034 DBMET00137 | DBMET01477 | |
| 0.232 | 0.055 | 0.341 | DNA methyltransferase I inhibitor | 0.222 0.059 DBMET01476 0.341 0.015 DBMET01477 0.139 0.117 DBMET00137 | DBMET01477 | |
| 0.191 | 0.014 | 0.258 | HIV-1 integrase (Overall Integration) inhibitor | 0.154 0.024 DBMET01476 0.258 0.005 DBMET01477 0.158 0.023 DBMET00137 | DBMET01477 | |
| 0.181 | 0.007 | 0.184 | Glutathione S-transferase inhibitor | 0.118 0.024 DBMET01476 0.184 0.007 DBMET01477 0.088 0.05 DBMET00137 | DBMET01477 | |
| 0.179 | 0.007 | 0.179 | Interleukin 5 antagonist | 0.091 0.053 DBMET01476 0.095 0.047 DBMET01477 | ||
| 0.181 | 0.017 | 0.202 | Carbonic anhydrase XIII inhibitor | 0.163 0.019 DBMET01476 0.202 0.014 DBMET01477 0.084 0.047 DBMET00137 | DBMET01477 | |
| 0.197 | 0.032 | 0.244 | Mannose-6-phosphate isomerase inhibitor | 0.243 0.014 DBMET01476 0.244 0.013 DBMET01477 0.215 0.023 DBMET00137 | DBMET01477 | |
| 0.176 | 0.014 | 0.265 | Prolactin inhibitor | 0.221 0.006 DBMET01476 0.265 0.004 DBMET01477 0.163 0.017 DBMET00137 | DBMET01477 | |
| 0.17 | 0.008 | 0.17 | Acetylcholine release stimulant | 0.143 0.021 DBMET01477 0.139 0.024 DBMET00137 | ||
| 0.171 | 0.009 | 0.174 | Anabolic | 0.151 0.017 DBMET01476 0.174 0.008 DBMET01477 0.147 0.019 DBMET00137 | DBMET01477 | |
| 0.173 | 0.015 | 0.33 | Folate antagonist | 0.219 0.007 DBMET01476 0.33 0.003 DBMET01477 | DBMET01477 | |
| 0.166 | 0.008 | 0.191 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.191 0.007 DBMET01476 0.181 0.007 DBMET01477 0.156 0.008 DBMET00137 | DBMET01476 | |
| 0.161 | 0.003 | 0.344 | Glutamate (mGluR6) antagonist | 0.159 0.004 DBMET01476 0.344 0.002 DBMET01477 0.114 0.007 DBMET00137 | DBMET01477 | |
| 0.16 | 0.003 | 0.16 | Lysophosphatidic acid 2 receptor antagonist | 0.036 0.015 DBMET01476 0.121 0.004 DBMET01477 0.032 0.019 DBMET00137 | ||
| 0.165 | 0.01 | 0.352 | Peroxisome proliferator-activated receptor gamma agonist | 0.101 0.027 DBMET01476 0.352 0.004 DBMET01477 | DBMET01477 | |
| 0.188 | 0.032 | 0.317 | DNA polymerase I inhibitor | 0.14 0.055 DBMET01476 0.317 0.01 DBMET01477 | DBMET01477 | |
| 0.221 | 0.066 | 0.337 | DNA methylase inhibitor | 0.209 0.073 DBMET01476 0.337 0.019 DBMET01477 0.136 0.131 DBMET00137 | DBMET01477 | |
| 0.168 | 0.013 | 0.183 | Toll-Like receptor 4 antagonist | 0.11 0.055 DBMET01476 0.183 0.009 DBMET01477 | DBMET01477 | |
| 0.233 | 0.079 | 0.233 | Antiamyloidogenic | 0.21 0.093 DBMET01477 | ||
| 0.162 | 0.009 | 0.162 | Leukotriene antagonist | 0.077 0.034 DBMET01476 0.149 0.01 DBMET01477 | ||
| 0.196 | 0.043 | 0.239 | Interleukin 6 antagonist | 0.239 0.025 DBMET01477 | DBMET01477 | |
| 0.185 | 0.033 | 0.302 | Protein-tyrosine phosphatase 1B inhibitor | 0.12 0.063 DBMET01476 0.302 0.01 DBMET01477 | DBMET01477 | |
| 0.154 | 0.004 | 0.154 | Interferon inducer | 0.067 0.04 DBMET01476 0.115 0.008 DBMET01477 0.075 0.029 DBMET00137 | ||
| 0.152 | 0.003 | 0.192 | Leukotriene B4 receptor 1 antagonist | 0.044 0.009 DBMET01476 0.192 0.003 DBMET01477 | DBMET01477 | |
| 0.171 | 0.023 | 0.2 | Interleukin 8 antagonist | 0.108 0.08 DBMET01476 0.2 0.013 DBMET01477 0.107 0.081 DBMET00137 | DBMET01477 | |
| 0.152 | 0.004 | 0.154 | Mannosidase inhibitor | 0.152 0.004 DBMET01476 0.154 0.004 DBMET01477 0.072 0.011 DBMET00137 | DBMET01477 | |
| 0.192 | 0.045 | 0.263 | Melanin inhibitor | 0.249 0.029 DBMET01476 0.263 0.027 DBMET01477 0.164 0.065 DBMET00137 | DBMET01477 | |
| 0.177 | 0.031 | 0.236 | Adenylate cyclase inhibitor | 0.116 0.071 DBMET01476 0.236 0.021 DBMET01477 0.122 0.066 DBMET00137 | DBMET01477 | |
| 0.159 | 0.013 | 0.54 | Cell adhesion molecule inhibitor | 0.1 0.035 DBMET01476 0.54 0.004 DBMET01477 | DBMET01477 | |
| 0.166 | 0.022 | 0.178 | Sphingosine 1-phosphate receptor 4 antagonist | 0.119 0.074 DBMET01476 0.178 0.015 DBMET01477 0.138 0.045 DBMET00137 | DBMET01477 | |
| 0.187 | 0.043 | 0.262 | Neurotensin receptor agonist | 0.189 0.041 DBMET01476 0.262 0.019 DBMET01477 0.179 0.05 DBMET00137 | DBMET01477 | |
| 0.153 | 0.011 | 0.166 | Toll-Like receptor 2 agonist | 0.07 0.018 DBMET01476 0.166 0.01 DBMET01477 0.044 0.027 DBMET00137 | DBMET01477 | |
| 0.151 | 0.008 | 0.407 | GABA aminotransferase inhibitor | 0.192 0.005 DBMET01476 0.407 0.003 DBMET01477 0.11 0.021 DBMET00137 | DBMET01477 | |
| 0.204 | 0.061 | 0.204 | P-glycoprotein inhibitor | 0.159 0.104 DBMET01477 | ||
| 0.152 | 0.01 | 0.19 | Ornithine decarboxylase inhibitor | 0.168 0.007 DBMET01476 0.19 0.005 DBMET01477 0.104 0.04 DBMET00137 | DBMET01477 | |
| 0.145 | 0.005 | 0.268 | Leukotriene A4 hydrolase inhibitor | 0.05 0.02 DBMET01476 0.268 0.004 DBMET01477 | DBMET01477 | |
| 0.185 | 0.046 | 0.201 | Thiol protease inhibitor | 0.201 0.039 DBMET01476 0.193 0.042 DBMET01477 0.13 0.097 DBMET00137 | DBMET01476 | |
| 0.143 | 0.004 | 0.143 | Alpha-mannosidase inhibitor | 0.128 0.004 DBMET01476 0.126 0.004 DBMET01477 0.083 0.01 DBMET00137 | ||
| 0.14 | 0.002 | 0.14 | GABA uptake inhibitor | 0.1 0.004 DBMET01476 0.115 0.003 DBMET01477 0.057 0.011 DBMET00137 | ||
| 0.177 | 0.039 | 0.195 | CF transmembrane conductance regulator agonist | 0.142 0.092 DBMET01476 0.195 0.024 DBMET01477 0.188 0.029 DBMET00137 | DBMET01477 | |
| 0.166 | 0.03 | 0.172 | Pregnane X receptor agonist | 0.134 0.089 DBMET01476 0.172 0.025 DBMET01477 0.152 0.05 DBMET00137 | DBMET01477 | |
| 0.146 | 0.011 | 0.146 | Phosphodiesterase III inhibitor | |||
| 0.14 | 0.005 | 0.205 | Leukotriene D4 antagonist | 0.031 0.015 DBMET01476 0.205 0.004 DBMET01477 | DBMET01477 | |
| 0.138 | 0.003 | 0.179 | Glutamate (mGluR1a) agonist | 0.112 0.003 DBMET01476 0.179 0.002 DBMET01477 0.05 0.005 DBMET00137 | DBMET01477 | |
| 0.138 | 0.004 | 0.172 | Purinergic P2Y12 antagonist | 0.022 0.017 DBMET01476 0.172 0.004 DBMET01477 | DBMET01477 | |
| 0.139 | 0.005 | 0.139 | Leukotriene B4 antagonist | 0.06 0.028 DBMET01476 0.113 0.008 DBMET01477 | ||
| 0.142 | 0.009 | 0.156 | Bile acid receptor antagonist | 0.109 0.032 DBMET01476 0.156 0.007 DBMET01477 0.098 0.053 DBMET00137 | DBMET01477 | |
| 0.155 | 0.022 | 0.155 | Sphingomyelinase inhibitor | 0.133 0.033 DBMET01477 0.127 0.036 DBMET00137 | ||
| 0.171 | 0.041 | 0.171 | Anesthetic local | 0.112 0.073 DBMET01477 0.094 0.088 DBMET00137 | ||
| 0.135 | 0.005 | 0.141 | Thromboxane antagonist | 0.089 0.015 DBMET01476 0.141 0.005 DBMET01477 | DBMET01477 | |
| 0.155 | 0.025 | 0.261 | Caspase 3 inhibitor | 0.261 0.005 DBMET01476 0.215 0.008 DBMET01477 0.103 0.086 DBMET00137 | DBMET01476 | |
| 0.138 | 0.008 | 0.149 | Granulocyte macrophage colony stimulating factor agonist | 0.117 0.018 DBMET01476 0.149 0.005 DBMET01477 0.141 0.007 DBMET00137 | DBMET01477 | |
| 0.134 | 0.004 | 0.145 | Thromboxane synthase inhibitor | 0.08 0.012 DBMET01476 0.145 0.004 DBMET01477 | DBMET01477 | |
| 0.139 | 0.009 | 0.281 | NMDA receptor agonist | 0.146 0.009 DBMET01476 0.281 0.003 DBMET01477 0.087 0.025 DBMET00137 | DBMET01477 | |
| 0.14 | 0.011 | 0.217 | Leukotriene synthesis inhibitor | 0.217 0.005 DBMET01476 0.217 0.005 DBMET01477 | DBMET01477 | |
| 0.155 | 0.026 | 0.191 | Potassium channel (Ca-activated) activator | 0.191 0.016 DBMET01477 | DBMET01477 | |
| 0.148 | 0.019 | 0.148 | Aminoacyl-tRNA synthetase inhibitor | 0.13 0.025 DBMET01477 | ||
| 0.158 | 0.03 | 0.198 | Heat shock protein 70 antagonist | 0.153 0.039 DBMET01476 0.198 0.007 DBMET01477 0.157 0.033 DBMET00137 | DBMET01477 | |
| 0.143 | 0.015 | 0.194 | Interleukin 12 antagonist | 0.194 0.006 DBMET01477 | DBMET01477 | |
| 0.157 | 0.032 | 0.157 | GABA receptor agonist | 0.157 0.032 DBMET01477 | ||
| 0.172 | 0.047 | 0.232 | Hemostatic | 0.232 0.024 DBMET01477 | DBMET01477 | |
| 0.195 | 0.071 | 0.274 | 5 Hydroxytryptamine 3E antagonist | 0.171 0.133 DBMET01476 0.204 0.055 DBMET01477 0.274 0.008 DBMET00137 | DBMET00137 | |
| 0.152 | 0.03 | 0.152 | Carbonic anhydrase XV inhibitor | 0.152 0.03 DBMET01477 0.15 0.031 DBMET00137 | ||
| 0.121 | 0.002 | 0.121 | Estrogen-related receptor beta antagonist | |||
| 0.137 | 0.019 | 0.143 | Macrophage migration inhibitory factor inhibitor | 0.072 0.064 DBMET01476 0.143 0.017 DBMET01477 0.07 0.066 DBMET00137 | DBMET01477 | |
| 0.148 | 0.032 | 0.148 | Bronchodilator | |||
| 0.122 | 0.006 | 0.298 | Prostaglandin F2 alpha antagonist | 0.123 0.006 DBMET01476 0.298 0.003 DBMET01477 | DBMET01477 | |
| 0.138 | 0.023 | 0.142 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.082 0.049 DBMET01476 0.142 0.021 DBMET01477 0.089 0.044 DBMET00137 | DBMET01477 | |
| 0.119 | 0.005 | 0.127 | Thromboxane A2 antagonist | 0.082 0.014 DBMET01476 0.127 0.005 DBMET01477 | DBMET01477 | |
| 0.186 | 0.073 | 0.203 | Nitric oxide antagonist | 0.189 0.072 DBMET01476 0.203 0.066 DBMET01477 | DBMET01477 | |
| 0.12 | 0.007 | 0.352 | Plasminogen activator inhibitor antagonist | 0.094 0.011 DBMET01476 0.352 0.003 DBMET01477 | DBMET01477 | |
| 0.146 | 0.034 | 0.146 | Protein kinase C gamma inhibitor | 0.097 0.081 DBMET01476 0.119 0.054 DBMET01477 0.102 0.074 DBMET00137 | ||
| 0.125 | 0.013 | 0.141 | Antimetabolite | 0.104 0.016 DBMET01476 0.141 0.012 DBMET01477 | DBMET01477 | |
| 0.156 | 0.045 | 0.206 | Monophenol monooxygenase inhibitor | 0.113 0.066 DBMET01476 0.206 0.032 DBMET01477 | DBMET01477 | |
| 0.116 | 0.006 | 0.427 | Sphingosine 1-phosphate receptor 5 agonist | 0.123 0.006 DBMET01476 0.427 0.003 DBMET01477 | DBMET01477 | |
| 0.122 | 0.012 | 0.141 | Carbonic anhydrase VB inhibitor | 0.052 0.042 DBMET01476 0.141 0.01 DBMET01477 0.073 0.026 DBMET00137 | DBMET01477 | |
| 0.127 | 0.018 | 0.239 | Glutamate release inhibitor | 0.132 0.015 DBMET01476 0.239 0.004 DBMET01477 0.137 0.014 DBMET00137 | DBMET01477 | |
| 0.133 | 0.024 | 0.215 | Thioredoxin inhibitor | 0.106 0.042 DBMET01476 0.215 0.007 DBMET01477 | DBMET01477 | |
| 0.122 | 0.014 | 0.469 | Prostaglandin EP2 antagonist | 0.168 0.008 DBMET01476 0.469 0.003 DBMET01477 | DBMET01477 | |
| 0.112 | 0.004 | 0.129 | Lysophosphatidic acid 3 receptor antagonist | 0.084 0.008 DBMET01476 0.129 0.003 DBMET01477 0.069 0.015 DBMET00137 | DBMET01477 | |
| 0.115 | 0.008 | 0.115 | Purinergic P2Y antagonist | 0.108 0.008 DBMET01477 | ||
| 0.167 | 0.061 | 0.208 | Hexokinase inhibitor | 0.187 0.043 DBMET01476 0.208 0.031 DBMET01477 0.162 0.066 DBMET00137 | DBMET01477 | |
| 0.114 | 0.008 | 0.139 | Phospholipase D inhibitor | 0.099 0.015 DBMET01476 0.139 0.004 DBMET01477 0.108 0.011 DBMET00137 | DBMET01477 | |
| 0.11 | 0.005 | 0.11 | Sphingosine kinase inhibitor | 0.056 0.047 DBMET01476 0.074 0.02 DBMET01477 0.06 0.038 DBMET00137 | ||
| 0.156 | 0.051 | 0.156 | Toll-Like receptor antagonist | 0.115 0.092 DBMET01477 | ||
| 0.109 | 0.005 | 0.109 | Sphingosine 1-phosphate receptor agonist | 0.049 0.026 DBMET01476 0.106 0.005 DBMET01477 | ||
| 0.109 | 0.005 | 0.119 | MDM2 inhibitor | 0.08 0.019 DBMET01476 0.119 0.004 DBMET01477 0.076 0.026 DBMET00137 | DBMET01477 | |
| 0.131 | 0.027 | 0.217 | Interleukin 1 beta converting enzyme inhibitor | 0.217 0.004 DBMET01476 0.192 0.007 DBMET01477 0.089 0.073 DBMET00137 | DBMET01476 | |
| 0.212 | 0.108 | 0.212 | Cardiotonic | |||
| 0.118 | 0.014 | 0.6 | Prostaglandin antagonist | 0.179 0.008 DBMET01476 0.6 0.004 DBMET01477 | DBMET01477 | |
| 0.139 | 0.036 | 0.157 | AMP-activated protein kinase stimulant | 0.157 0.024 DBMET01477 | DBMET01477 | |
| 0.127 | 0.024 | 0.161 | Lanosterol 14 alpha demethylase inhibitor | 0.107 0.046 DBMET01476 0.161 0.008 DBMET01477 0.131 0.021 DBMET00137 | DBMET01477 | |
| 0.114 | 0.011 | 0.114 | Glycine transporter 2 inhibitor | 0.107 0.012 DBMET01477 | ||
| 0.11 | 0.009 | 0.11 | Phosphodiesterase 3B inhibitor | |||
| 0.105 | 0.007 | 0.105 | Nitric oxide donor | 0.092 0.013 DBMET01477 | ||
| 0.106 | 0.009 | 0.106 | MAP kinase kinase 7 inhibitor | 0.076 0.059 DBMET01476 0.101 0.012 DBMET01477 0.095 0.017 DBMET00137 | ||
| 0.101 | 0.005 | 0.27 | Prostacyclin antagonist | 0.068 0.007 DBMET01476 0.27 0.003 DBMET01477 | DBMET01477 | |
| 0.139 | 0.043 | 0.164 | DNA repair enzyme inhibitor | 0.114 0.086 DBMET01476 0.164 0.021 DBMET01477 0.126 0.061 DBMET00137 | DBMET01477 | |
| 0.099 | 0.003 | 0.189 | Prostacyclin agonist | 0.048 0.004 DBMET01476 0.189 0.002 DBMET01477 | DBMET01477 | |
| 0.1 | 0.004 | 0.135 | Glutamate (mGluR1) agonist | 0.047 0.005 DBMET01476 0.135 0.003 DBMET01477 0.03 0.01 DBMET00137 | DBMET01477 | |
| 0.11 | 0.014 | 0.11 | Neuraminidase (influenza) inhibitor | 0.075 0.03 DBMET01477 | ||
| 0.115 | 0.019 | 0.119 | Na+ K+ transporting ATPase inhibitor | 0.118 0.018 DBMET01476 0.119 0.017 DBMET01477 0.105 0.027 DBMET00137 | DBMET01477 | |
| 0.142 | 0.047 | 0.155 | Beta amyloid protein antagonist | 0.155 0.037 DBMET01477 | DBMET01477 | |
| 0.102 | 0.007 | 0.102 | Phosphoglycerate kinase inhibitor | 0.044 0.016 DBMET01476 0.087 0.008 DBMET01477 0.042 0.018 DBMET00137 | ||
| 0.099 | 0.004 | 0.118 | Arginase inhibitor | 0.073 0.007 DBMET01476 0.118 0.003 DBMET01477 0.051 0.014 DBMET00137 | DBMET01477 | |
| 0.104 | 0.009 | 0.128 | 5-Alpha-reductase inhibitor | 0.044 0.021 DBMET01476 0.128 0.008 DBMET01477 | DBMET01477 | |
| 0.098 | 0.004 | 0.098 | Sphingosine 1-phosphate receptor 1 agonist | 0.048 0.021 DBMET01476 0.088 0.005 DBMET01477 | ||
| 0.125 | 0.032 | 0.125 | Calcium antagonist | 0.107 0.043 DBMET01477 0.101 0.047 DBMET00137 | ||
| 0.095 | 0.002 | 0.095 | HMG CoA reductase inhibitor | 0.041 0.014 DBMET01476 0.075 0.004 DBMET01477 | ||
| 0.114 | 0.022 | 0.168 | Glycine receptor antagonist | 0.116 0.02 DBMET01476 0.168 0.005 DBMET01477 0.128 0.014 DBMET00137 | DBMET01477 | |
| 0.096 | 0.004 | 0.123 | Membrane dipeptidase inhibitor | 0.083 0.005 DBMET01476 0.123 0.003 DBMET01477 0.055 0.012 DBMET00137 | DBMET01477 | |
| 0.1 | 0.008 | 0.1 | Glucosylceramidase inhibitor | 0.05 0.047 DBMET01476 0.065 0.026 DBMET01477 0.056 0.036 DBMET00137 | ||
| 0.093 | 0.003 | 0.173 | Glutamate (mGluR8) agonist | 0.115 0.003 DBMET01476 0.173 0.001 DBMET01477 0.073 0.005 DBMET00137 | DBMET01477 | |
| 0.12 | 0.03 | 0.532 | ABCA1 expression enhancer | 0.532 0.003 DBMET01476 0.185 0.011 DBMET01477 | DBMET01476 | |
| 0.095 | 0.005 | 0.147 | Prostaglandin agonist | 0.047 0.011 DBMET01476 0.147 0.004 DBMET01477 | DBMET01477 | |
| 0.134 | 0.045 | 0.148 | Falcipain 3 inhibitor | 0.142 0.04 DBMET01476 0.141 0.041 DBMET01477 0.148 0.038 DBMET00137 | DBMET00137 | |
| 0.119 | 0.031 | 0.181 | Glutamate (mGluR7) agonist | 0.116 0.035 DBMET01476 0.181 0.005 DBMET01477 0.131 0.021 DBMET00137 | DBMET01477 | |
| 0.092 | 0.005 | 0.243 | Glutamate (mGluR3) antagonist | 0.062 0.008 DBMET01476 0.243 0.003 DBMET01477 0.048 0.014 DBMET00137 | DBMET01477 | |
| 0.14 | 0.054 | 0.2 | Cathepsin H inhibitor | 0.2 0.022 DBMET01476 0.197 0.023 DBMET01477 0.168 0.035 DBMET00137 | DBMET01476 | |
| 0.102 | 0.015 | 0.132 | Vanilloid 4 agonist | 0.098 0.018 DBMET01476 0.132 0.004 DBMET01477 0.109 0.011 DBMET00137 | DBMET01477 | |
| 0.132 | 0.046 | 0.246 | TRPA1 agonist | 0.246 0.005 DBMET01476 0.189 0.013 DBMET01477 0.131 0.047 DBMET00137 | DBMET01476 | |
| 0.11 | 0.024 | 0.149 | Carbonic anhydrase V inhibitor | 0.149 0.015 DBMET01477 0.07 0.042 DBMET00137 | DBMET01477 | |
| 0.093 | 0.007 | 0.095 | Sphingosine 1-phosphate receptor 3 agonist | 0.095 0.007 DBMET01477 | DBMET01477 | |
| 0.092 | 0.007 | 0.092 | Adenosine deaminase inhibitor | 0.076 0.01 DBMET01476 0.082 0.009 DBMET01477 0.06 0.021 DBMET00137 | ||
| 0.202 | 0.116 | 0.25 | Neuropeptide Y2 antagonist | 0.25 0.057 DBMET01477 0.21 0.103 DBMET00137 | DBMET01477 | |
| 0.1 | 0.015 | 0.1 | Neuraminidase inhibitor | 0.074 0.03 DBMET01477 | ||
| 0.088 | 0.005 | 0.088 | Adenylate cyclase 1 inhibitor | 0.079 0.008 DBMET01477 0.088 0.005 DBMET00137 | ||
| 0.112 | 0.03 | 0.172 | Transcription factor NF kappa B stimulant | 0.086 0.057 DBMET01476 0.172 0.012 DBMET01477 | DBMET01477 | |
| 0.118 | 0.037 | 0.118 | MAP kinase kinase 1 inhibitor | 0.083 0.081 DBMET01477 0.101 0.055 DBMET00137 | ||
| 0.091 | 0.01 | 0.091 | Sphingosine kinase 2 inhibitor | 0.063 0.029 DBMET01477 0.067 0.024 DBMET00137 | ||
| 0.095 | 0.013 | 0.113 | Peroxisome proliferator-activated receptor alpha agonist | 0.049 0.033 DBMET01476 0.113 0.01 DBMET01477 | DBMET01477 | |
| 0.098 | 0.017 | 0.109 | Peroxisome proliferator-activated receptor gamma antagonist | 0.077 0.039 DBMET01476 0.109 0.012 DBMET01477 | DBMET01477 | |
| 0.098 | 0.018 | 0.139 | NMDA receptor glycine site agonist | 0.086 0.024 DBMET01476 0.139 0.005 DBMET01477 0.092 0.021 DBMET00137 | DBMET01477 | |
| 0.104 | 0.023 | 0.138 | Carbonic anhydrase VA inhibitor | 0.063 0.055 DBMET01476 0.138 0.013 DBMET01477 0.076 0.04 DBMET00137 | DBMET01477 | |
| 0.091 | 0.011 | 0.091 | Sphingosine 1-phosphate receptor 3 antagonist | 0.09 0.011 DBMET01477 0.058 0.042 DBMET00137 | ||
| 0.097 | 0.018 | 0.167 | Purinergic P2X1 antagonist | 0.127 0.01 DBMET01476 0.167 0.005 DBMET01477 0.123 0.011 DBMET00137 | DBMET01477 | |
| 0.124 | 0.045 | 0.161 | Xanthine oxidase inhibitor | 0.096 0.064 DBMET01476 0.161 0.03 DBMET01477 0.084 0.083 DBMET00137 | DBMET01477 | |
| 0.108 | 0.029 | 0.315 | Hematopoietic | 0.092 0.047 DBMET01476 0.315 0.005 DBMET01477 | DBMET01477 | |
| 0.098 | 0.02 | 0.115 | Ribonucleoside-diphosphate reductase inhibitor | 0.092 0.021 DBMET01476 0.115 0.016 DBMET01477 | DBMET01477 | |
| 0.098 | 0.021 | 0.114 | Ribonucleotide reductase inhibitor | 0.092 0.023 DBMET01476 0.114 0.018 DBMET01477 | DBMET01477 | |
| 0.079 | 0.002 | 0.079 | Lysophosphatidic acid receptor 1 agonist | 0.04 0.005 DBMET01476 0.068 0.003 DBMET01477 0.035 0.008 DBMET00137 | ||
| 0.125 | 0.048 | 0.172 | 5-Lipoxygenase inhibitor | 0.172 0.031 DBMET01477 | DBMET01477 | |
| 0.083 | 0.007 | 0.102 | Leukotriene C antagonist | 0.071 0.013 DBMET01476 0.102 0.004 DBMET01477 0.058 0.035 DBMET00137 | DBMET01477 | |
| 0.082 | 0.007 | 0.142 | Thymidylate synthase inhibitor | 0.142 0.003 DBMET01476 0.115 0.004 DBMET01477 0.047 0.031 DBMET00137 | DBMET01476 | |
| 0.077 | 0.003 | 0.104 | Glutamate (mGluR3) agonist | 0.061 0.004 DBMET01476 0.104 0.002 DBMET01477 0.042 0.008 DBMET00137 | DBMET01477 | |
| 0.086 | 0.012 | 0.116 | Sphingosine 1-phosphate receptor 1 antagonist | 0.055 0.041 DBMET01476 0.116 0.006 DBMET01477 | DBMET01477 | |
| 0.075 | 0.002 | 0.075 | Lysophosphatidic acid receptor 3 agonist | 0.023 0.005 DBMET01476 0.049 0.002 DBMET01477 0.023 0.005 DBMET00137 | ||
| 0.079 | 0.007 | 0.099 | Pregnane X receptor antagonist | 0.08 0.007 DBMET01476 0.099 0.004 DBMET01477 0.078 0.007 DBMET00137 | DBMET01477 | |
| 0.077 | 0.005 | 0.077 | Retinoic acid alpha receptor agonist | 0.069 0.006 DBMET01477 | ||
| 0.074 | 0.003 | 0.079 | Prostaglandin F2 alpha agonist | 0.054 0.004 DBMET01476 0.079 0.002 DBMET01477 0.027 0.011 DBMET00137 | DBMET01477 | |
| 0.076 | 0.005 | 0.078 | Geranyltranstransferase inhibitor | 0.07 0.008 DBMET01476 0.078 0.005 DBMET01477 0.061 0.013 DBMET00137 | DBMET01477 | |
| 0.075 | 0.004 | 0.075 | Uridine phosphorylase inhibitor | 0.038 0.013 DBMET01476 0.071 0.004 DBMET01477 0.049 0.008 DBMET00137 | ||
| 0.15 | 0.08 | 0.358 | Anticoagulant | 0.312 0.026 DBMET01476 0.358 0.02 DBMET01477 | DBMET01477 | |
| 0.108 | 0.038 | 0.113 | Phosphodiesterase 6D inhibitor | 0.113 0.032 DBMET01477 0.099 0.055 DBMET00137 | DBMET01477 | |
| 0.088 | 0.018 | 0.654 | Integrin antagonist | 0.086 0.019 DBMET01476 0.654 0.004 DBMET01477 | DBMET01477 | |
| 0.08 | 0.01 | 0.08 | Squalene epoxidase inhibitor | 0.057 0.024 DBMET01477 0.063 0.018 DBMET00137 | ||
| 0.095 | 0.025 | 0.126 | Sphingosine 1-phosphate receptor antagonist | 0.126 0.011 DBMET01477 | DBMET01477 | |
| 0.077 | 0.008 | 0.128 | Retinoid X alpha receptor agonist | 0.061 0.011 DBMET01476 0.128 0.004 DBMET01477 0.04 0.019 DBMET00137 | DBMET01477 | |
| 0.072 | 0.004 | 0.127 | Kainate receptor agonist | 0.076 0.004 DBMET01476 0.127 0.002 DBMET01477 0.067 0.005 DBMET00137 | DBMET01477 | |
| 0.07 | 0.003 | 0.097 | G-protein-coupled receptor 120 agonist | 0.026 0.006 DBMET01476 0.097 0.003 DBMET01477 | DBMET01477 | |
| 0.071 | 0.005 | 0.071 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.061 0.007 DBMET01476 0.065 0.006 DBMET01477 0.052 0.008 DBMET00137 | ||
| 0.087 | 0.021 | 0.145 | NMDA 2C receptor antagonist | 0.063 0.041 DBMET01476 0.145 0.007 DBMET01477 | DBMET01477 | |
| 0.085 | 0.02 | 0.113 | Exportin-1 inhibitor | 0.083 0.022 DBMET01476 0.105 0.007 DBMET01477 0.113 0.005 DBMET00137 | DBMET00137 | |
| 0.145 | 0.08 | 0.145 | Cytidine deaminase inhibitor | 0.129 0.092 DBMET01477 0.132 0.089 DBMET00137 | ||
| 0.069 | 0.004 | 0.113 | Prostaglandin D2 agonist | 0.064 0.005 DBMET01476 0.113 0.003 DBMET01477 | DBMET01477 | |
| 0.074 | 0.009 | 0.11 | Retinoid X receptor agonist | 0.067 0.011 DBMET01476 0.11 0.004 DBMET01477 0.038 0.024 DBMET00137 | DBMET01477 | |
| 0.069 | 0.005 | 0.074 | Guanylate cyclase inhibitor | 0.056 0.016 DBMET01476 0.074 0.004 DBMET01477 0.068 0.005 DBMET00137 | DBMET01477 | |
| 0.074 | 0.01 | 0.074 | Thymidine kinase inhibitor | 0.038 0.034 DBMET01476 0.064 0.012 DBMET01477 0.05 0.019 DBMET00137 | ||
| 0.076 | 0.012 | 0.076 | Aldosterone antagonist | 0.062 0.018 DBMET01477 0.056 0.023 DBMET00137 | ||
| 0.073 | 0.009 | 0.156 | Glutamate (mGluR4) antagonist | 0.072 0.01 DBMET01476 0.156 0.004 DBMET01477 0.053 0.018 DBMET00137 | DBMET01477 | |
| 0.069 | 0.005 | 0.143 | Lysine carboxypeptidase inhibitor | 0.063 0.006 DBMET01476 0.143 0.003 DBMET01477 0.033 0.013 DBMET00137 | DBMET01477 | |
| 0.084 | 0.022 | 0.084 | Xanthine dehydrogenase inhibitor | 0.068 0.033 DBMET01476 0.074 0.029 DBMET01477 | ||
| 0.069 | 0.008 | 0.069 | Neuraminidase (Influenza A) inhibitor | 0.056 0.016 DBMET01477 | ||
| 0.1 | 0.039 | 0.1 | Acetylcholine nicotinic antagonist | 0.077 0.057 DBMET01477 | ||
| 0.104 | 0.042 | 0.123 | Histamine N-methyltransferase inhibitor | 0.122 0.028 DBMET01477 0.123 0.028 DBMET00137 | DBMET00137 | |
| 0.063 | 0.002 | 0.091 | Carbonic anhydrase VIII inhibitor | 0.053 0.002 DBMET01476 0.091 0.001 DBMET01477 0.037 0.004 DBMET00137 | DBMET01477 | |
| 0.063 | 0.002 | 0.091 | Carbonic anhydrase X inhibitor | 0.053 0.002 DBMET01476 0.091 0.001 DBMET01477 0.037 0.004 DBMET00137 | DBMET01477 | |
| 0.084 | 0.023 | 0.128 | Glutamate (mGluR7) antagonist | 0.094 0.014 DBMET01476 0.128 0.004 DBMET01477 0.112 0.006 DBMET00137 | DBMET01477 | |
| 0.076 | 0.016 | 0.08 | Lipocortins synthesis agonist | 0.061 0.033 DBMET01476 0.08 0.013 DBMET01477 | DBMET01477 | |
| 0.067 | 0.007 | 0.067 | Sphingosine kinase 1 inhibitor | 0.044 0.024 DBMET01477 0.039 0.032 DBMET00137 | ||
| 0.083 | 0.023 | 0.12 | Maillard reaction inhibitor | 0.12 0.01 DBMET01477 | DBMET01477 | |
| 0.142 | 0.082 | 0.144 | Acetylcholine M1 receptor antagonist | 0.144 0.08 DBMET01477 | DBMET01477 | |
| 0.084 | 0.025 | 0.084 | Beta adrenoreceptor antagonist | 0.076 0.031 DBMET01477 | ||
| 0.077 | 0.018 | 0.084 | Phosphorylase inhibitor | 0.068 0.021 DBMET01476 0.084 0.016 DBMET01477 | DBMET01477 | |
| 0.226 | 0.167 | 0.262 | Calpain 2 inhibitor | 0.262 0.141 DBMET01476 0.238 0.158 DBMET01477 0.21 0.179 DBMET00137 | DBMET01476 | |
| 0.07 | 0.012 | 0.079 | Heparanase inhibitor | 0.067 0.015 DBMET01476 0.079 0.007 DBMET01477 0.055 0.033 DBMET00137 | DBMET01477 | |
| 0.083 | 0.026 | 0.083 | Protein kinase C beta inhibitor | 0.076 0.037 DBMET01477 0.071 0.046 DBMET00137 | ||
| 0.082 | 0.025 | 0.099 | Protease 3C (Human rhinovirus) inhibitor | 0.099 0.016 DBMET01476 0.095 0.018 DBMET01477 0.082 0.026 DBMET00137 | DBMET01476 | |
| 0.065 | 0.009 | 0.065 | Cytokine production stimulant | 0.056 0.018 DBMET01477 0.056 0.018 DBMET00137 | ||
| 0.074 | 0.019 | 0.092 | Carbonic anhydrase XIV inhibitor | 0.092 0.013 DBMET01477 | DBMET01477 | |
| 0.093 | 0.038 | 0.13 | Caspase 7 inhibitor | 0.109 0.02 DBMET01476 0.13 0.011 DBMET01477 0.087 0.047 DBMET00137 | DBMET01477 | |
| 0.06 | 0.006 | 0.072 | Retinoid X receptor antagonist | 0.053 0.01 DBMET01476 0.072 0.004 DBMET01477 0.043 0.019 DBMET00137 | DBMET01477 | |
| 0.063 | 0.008 | 0.097 | Purinergic P2T antagonist | 0.097 0.005 DBMET01477 | DBMET01477 | |
| 0.064 | 0.01 | 0.098 | Dihydropteroate synthase inhibitor | 0.046 0.02 DBMET01476 0.098 0.005 DBMET01477 0.049 0.018 DBMET00137 | DBMET01477 | |
| 0.059 | 0.005 | 0.082 | Prostaglandin EP2 agonist | 0.042 0.008 DBMET01476 0.082 0.004 DBMET01477 | DBMET01477 | |
| 0.061 | 0.007 | 0.08 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.053 0.012 DBMET01476 0.08 0.004 DBMET01477 0.072 0.004 DBMET00137 | DBMET01477 | |
| 0.078 | 0.025 | 0.078 | Beta 3 adrenoreceptor antagonist | 0.073 0.03 DBMET01477 0.06 0.056 DBMET00137 | ||
| 0.056 | 0.003 | 0.056 | Estrogen-related receptor gamma antagonist | 0.038 0.006 DBMET01477 0.034 0.009 DBMET00137 | ||
| 0.059 | 0.006 | 0.076 | Leukotriene C4 antagonist | 0.048 0.012 DBMET01476 0.076 0.004 DBMET01477 0.037 0.032 DBMET00137 | DBMET01477 | |
| 0.063 | 0.01 | 0.076 | Nicotinic acid receptor agonist | 0.076 0.007 DBMET01477 0.032 0.031 DBMET00137 | DBMET01477 | |
| 0.063 | 0.011 | 0.119 | GABA B receptor antagonist | 0.048 0.022 DBMET01476 0.119 0.004 DBMET01477 0.042 0.032 DBMET00137 | DBMET01477 | |
| 0.084 | 0.032 | 0.133 | Potassium channel large-conductance Ca-activated activator | 0.133 0.014 DBMET01477 | DBMET01477 | |
| 0.075 | 0.025 | 0.23 | Aldose reductase inhibitor | 0.089 0.02 DBMET01476 0.23 0.006 DBMET01477 | DBMET01477 | |
| 0.094 | 0.043 | 0.094 | Myeloperoxidase inhibitor | 0.091 0.047 DBMET01477 0.085 0.057 DBMET00137 | ||
| 0.093 | 0.042 | 0.108 | mTOR complex 2 inhibitor | 0.091 0.045 DBMET01477 0.108 0.025 DBMET00137 | DBMET00137 | |
| 0.088 | 0.038 | 0.204 | Cathepsin G inhibitor | 0.198 0.016 DBMET01476 0.204 0.016 DBMET01477 0.072 0.051 DBMET00137 | DBMET01477 | |
| 0.061 | 0.011 | 0.076 | Squalene synthetase inhibitor | 0.076 0.009 DBMET01477 | DBMET01477 | |
| 0.062 | 0.012 | 0.146 | Glutamate (mGluR group III) antagonist | 0.061 0.012 DBMET01476 0.146 0.004 DBMET01477 0.05 0.021 DBMET00137 | DBMET01477 | |
| 0.068 | 0.019 | 0.068 | Nicotinic alpha3beta2 receptor antagonist | 0.053 0.037 DBMET01477 0.063 0.023 DBMET00137 | ||
| 0.161 | 0.112 | 0.166 | MAP kinase kinase 2 inhibitor | 0.138 0.132 DBMET01477 0.166 0.107 DBMET00137 | DBMET00137 | |
| 0.07 | 0.022 | 0.077 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.075 0.018 DBMET01477 0.077 0.018 DBMET00137 | DBMET00137 | |
| 0.05 | 0.002 | 0.061 | Thromboxane A2 agonist | 0.04 0.002 DBMET01476 0.061 0.002 DBMET01477 0.021 0.005 DBMET00137 | DBMET01477 | |
| 0.058 | 0.011 | 0.069 | Farnesoid X receptor agonist | 0.041 0.023 DBMET01476 0.069 0.007 DBMET01477 | DBMET01477 | |
| 0.051 | 0.005 | 0.348 | Free fatty acid receptor 1 agonist | 0.055 0.005 DBMET01476 0.348 0.003 DBMET01477 | DBMET01477 | |
| 0.053 | 0.007 | 0.058 | Vanilloid 3 antagonist | 0.058 0.005 DBMET01477 0.046 0.012 DBMET00137 | DBMET01477 | |
| 0.071 | 0.025 | 0.071 | Beta 1 adrenoreceptor antagonist | 0.067 0.029 DBMET01477 | ||
| 0.06 | 0.014 | 0.132 | AICAR transformylase inhibitor | 0.131 0.004 DBMET01476 0.132 0.003 DBMET01477 0.054 0.018 DBMET00137 | DBMET01477 | |
| 0.053 | 0.008 | 0.075 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.036 0.022 DBMET01476 0.075 0.005 DBMET01477 | DBMET01477 | |
| 0.051 | 0.006 | 0.06 | Retinoid X alpha receptor antagonist | 0.044 0.011 DBMET01476 0.06 0.004 DBMET01477 0.039 0.017 DBMET00137 | DBMET01477 | |
| 0.078 | 0.033 | 0.099 | Neutrophil collagenase inhibitor | 0.072 0.038 DBMET01476 0.099 0.022 DBMET01477 | DBMET01477 | |
| 0.066 | 0.022 | 0.101 | Diacylglycerol O-acyltransferase inhibitor | 0.062 0.024 DBMET01476 0.101 0.007 DBMET01477 | DBMET01477 | |
| 0.057 | 0.013 | 0.118 | Kainate receptor 2 antagonist | 0.058 0.012 DBMET01476 0.118 0.004 DBMET01477 0.033 0.028 DBMET00137 | DBMET01477 | |
| 0.052 | 0.008 | 0.088 | Free fatty acid receptor 1 antagonist | 0.048 0.01 DBMET01476 0.088 0.004 DBMET01477 0.036 0.02 DBMET00137 | DBMET01477 | |
| 0.051 | 0.008 | 0.051 | Carnitine palmitoyltransferase inhibitor | 0.05 0.008 DBMET01477 | ||
| 0.062 | 0.019 | 0.062 | Potassium channel Kv1.3 blocker | 0.042 0.039 DBMET01477 0.041 0.04 DBMET00137 | ||
| 0.049 | 0.006 | 0.102 | Prostaglandin E2 agonist | 0.03 0.01 DBMET01476 0.102 0.004 DBMET01477 | DBMET01477 | |
| 0.045 | 0.003 | 0.045 | Isoleucine-tRNA ligase inhibitor | 0.024 0.012 DBMET01476 0.034 0.004 DBMET01477 0.026 0.01 DBMET00137 | ||
| 0.049 | 0.007 | 0.049 | Ceramide glucosyltransferase inhibitor | 0.047 0.009 DBMET01477 0.038 0.021 DBMET00137 | ||
| 0.046 | 0.005 | 0.046 | Calcium-independent phospholipase A2 inhibitor | 0.035 0.022 DBMET01476 0.046 0.005 DBMET01477 | ||
| 0.049 | 0.008 | 0.049 | Carnitine palmitoyltransferase 1 inhibitor | 0.048 0.009 DBMET01477 | ||
| 0.146 | 0.106 | 0.154 | Amyloid beta precursor protein antagonist | 0.154 0.097 DBMET01476 0.151 0.101 DBMET01477 | DBMET01476 | |
| 0.057 | 0.016 | 0.057 | Glutamate (mGluR1a) antagonist | 0.04 0.03 DBMET01477 0.041 0.028 DBMET00137 | ||
| 0.112 | 0.071 | 0.113 | Estrogen antagonist | 0.113 0.068 DBMET01477 | DBMET01477 | |
| 0.045 | 0.004 | 0.06 | Prostaglandin H2 antagonist | 0.04 0.005 DBMET01476 0.06 0.003 DBMET01477 | DBMET01477 | |
| 0.067 | 0.027 | 0.067 | Beta 2 adrenoreceptor agonist | 0.065 0.033 DBMET01477 0.059 0.054 DBMET00137 | ||
| 0.085 | 0.045 | 0.089 | Nicotinic alpha4beta2 receptor antagonist | 0.075 0.056 DBMET01477 0.089 0.041 DBMET00137 | DBMET00137 | |
| 0.054 | 0.014 | 0.075 | Dihydrofolate reductase inhibitor | 0.075 0.005 DBMET01476 0.068 0.007 DBMET01477 | DBMET01476 | |
| 0.117 | 0.077 | 0.117 | Cholinergic antagonist | |||
| 0.063 | 0.024 | 0.064 | Epithelial sodium channel blocker | 0.064 0.023 DBMET01477 0.063 0.025 DBMET00137 | DBMET01477 | |
| 0.088 | 0.049 | 0.12 | D-Ala-D-Ala ligase inhibitor | 0.087 0.051 DBMET01476 0.12 0.013 DBMET01477 0.115 0.016 DBMET00137 | DBMET01477 | |
| 0.047 | 0.008 | 0.047 | Cholesterol ester transfer protein antagonist | 0.041 0.012 DBMET01477 | ||
| 0.058 | 0.019 | 0.073 | Fructose-1,6-bisphosphatase inhibitor | 0.073 0.01 DBMET01477 0.046 0.029 DBMET00137 | DBMET01477 | |
| 0.079 | 0.04 | 0.106 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.095 0.017 DBMET01477 0.106 0.01 DBMET00137 | DBMET00137 | |
| 0.043 | 0.004 | 0.043 | DNA polymerase III inhibitor | |||
| 0.057 | 0.019 | 0.068 | Dopamine beta hydroxylase inhibitor | 0.048 0.035 DBMET01476 0.068 0.009 DBMET01477 0.063 0.012 DBMET00137 | DBMET01477 | |
| 0.065 | 0.026 | 0.097 | Ryanodine receptor antagonist | 0.063 0.029 DBMET01476 0.097 0.005 DBMET01477 0.075 0.012 DBMET00137 | DBMET01477 | |
| 0.046 | 0.007 | 0.083 | 5-Alpha-reductase 1 inhibitor | 0.083 0.005 DBMET01477 | DBMET01477 | |
| 0.081 | 0.042 | 0.177 | CDC25A inhibitor | 0.079 0.044 DBMET01476 0.177 0.009 DBMET01477 | DBMET01477 | |
| 0.058 | 0.02 | 0.146 | NMDA receptor subunit 3B antagonist | 0.039 0.036 DBMET01476 0.146 0.006 DBMET01477 | DBMET01477 | |
| 0.047 | 0.01 | 0.103 | Glutamate (mGluR8) antagonist | 0.061 0.005 DBMET01476 0.103 0.003 DBMET01477 | DBMET01477 | |
| 0.053 | 0.016 | 0.068 | Calcitonin receptor agonist | 0.046 0.018 DBMET01476 0.068 0.013 DBMET01477 0.033 0.024 DBMET00137 | DBMET01477 | |
| 0.064 | 0.026 | 0.431 | GP IIb/IIIa receptor antagonist | 0.078 0.022 DBMET01476 0.431 0.004 DBMET01477 | DBMET01477 | |
| 0.08 | 0.042 | 0.095 | Epoxide hydrolase inhibitor | 0.095 0.029 DBMET01477 | DBMET01477 | |
| 0.05 | 0.013 | 0.086 | Peroxisome proliferator-activated receptor delta agonist | 0.034 0.022 DBMET01476 0.086 0.007 DBMET01477 | DBMET01477 | |
| 0.057 | 0.02 | 0.071 | Carbonic anhydrase IV inhibitor | 0.071 0.014 DBMET01477 | DBMET01477 | |
| 0.068 | 0.032 | 0.085 | Androgen agonist | 0.085 0.021 DBMET01477 0.067 0.034 DBMET00137 | DBMET01477 | |
| 0.057 | 0.02 | 0.068 | Carnitine palmitoyltransferase 1B inhibitor | 0.068 0.012 DBMET01477 | DBMET01477 | |
| 0.039 | 0.003 | 0.061 | Thromboxane agonist | 0.027 0.003 DBMET01476 0.061 0.002 DBMET01477 0.01 0.008 DBMET00137 | DBMET01477 | |
| 0.039 | 0.003 | 0.039 | Estrogen-related receptor gamma agonist | 0.024 0.006 DBMET01477 0.017 0.016 DBMET00137 | ||
| 0.082 | 0.046 | 0.086 | Estrogen receptor alpha antagonist | 0.086 0.04 DBMET01477 | DBMET01477 | |
| 0.052 | 0.016 | 0.084 | Dopamine D5 agonist | 0.046 0.021 DBMET01476 0.084 0.005 DBMET01477 0.078 0.006 DBMET00137 | DBMET01477 | |
| 0.039 | 0.004 | 0.039 | Retinoic acid beta receptor agonist | 0.027 0.006 DBMET01477 | ||
| 0.058 | 0.023 | 0.183 | CD45 antagonist | 0.073 0.014 DBMET01476 0.183 0.005 DBMET01477 0.047 0.042 DBMET00137 | DBMET01477 | |
| 0.175 | 0.141 | 0.241 | Calpain inhibitor | 0.241 0.074 DBMET01476 0.225 0.09 DBMET01477 0.188 0.125 DBMET00137 | DBMET01476 | |
| 0.055 | 0.021 | 0.06 | Oxytocin agonist | 0.039 0.033 DBMET01476 0.06 0.017 DBMET01477 0.058 0.019 DBMET00137 | DBMET01477 | |
| 0.045 | 0.011 | 0.244 | Peroxisome proliferator-activated receptor delta antagonist | 0.043 0.012 DBMET01476 0.244 0.004 DBMET01477 | DBMET01477 | |
| 0.068 | 0.034 | 0.278 | Caspase 9 inhibitor | 0.278 0.003 DBMET01476 0.236 0.004 DBMET01477 | DBMET01476 | |
| 0.143 | 0.109 | 0.165 | Tumour necrosis factor antagonist | 0.165 0.082 DBMET01477 | DBMET01477 | |
| 0.109 | 0.076 | 0.143 | Proteasome inhibitor | 0.143 0.05 DBMET01476 0.141 0.052 DBMET01477 0.1 0.088 DBMET00137 | DBMET01476 | |
| 0.041 | 0.008 | 0.05 | LFA antagonist | 0.05 0.005 DBMET01477 | DBMET01477 | |
| 0.046 | 0.012 | 0.271 | Integrin alpha4 antagonist | 0.021 0.02 DBMET01476 0.271 0.004 DBMET01477 | DBMET01477 | |
| 0.039 | 0.005 | 0.039 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.032 0.009 DBMET01477 0.031 0.01 DBMET00137 | ||
| 0.073 | 0.04 | 0.128 | Glucagon-like peptide 1 agonist | 0.069 0.042 DBMET01476 0.128 0.012 DBMET01477 | DBMET01477 | |
| 0.145 | 0.112 | 0.145 | Amyloid beta aggregation inhibitor | |||
| 0.036 | 0.003 | 0.036 | Vitamin D receptor agonist | 0.016 0.012 DBMET01476 0.025 0.004 DBMET01477 | ||
| 0.041 | 0.009 | 0.041 | Carnitine palmitoyltransferase 1A inhibitor | |||
| 0.133 | 0.101 | 0.136 | MAP kinase 3 inhibitor | 0.131 0.104 DBMET01477 0.136 0.092 DBMET00137 | DBMET00137 | |
| 0.089 | 0.058 | 0.1 | ATPase (Vacuolar H+) inhibitor | 0.1 0.039 DBMET01477 | DBMET01477 | |
| 0.129 | 0.098 | 0.186 | NOS3 expression enhancer | 0.186 0.047 DBMET01477 | DBMET01477 | |
| 0.084 | 0.053 | 0.084 | Adrenaline agonist | 0.084 0.052 DBMET01477 | ||
| 0.057 | 0.027 | 0.059 | Beta 2 adrenoreceptor antagonist | 0.059 0.025 DBMET01477 | DBMET01477 | |
| 0.11 | 0.08 | 0.11 | Acetylcholine antagonist | |||
| 0.049 | 0.018 | 0.069 | G protein-coupled receptor agonist | 0.069 0.01 DBMET01477 | DBMET01477 | |
| 0.064 | 0.034 | 0.082 | Potassium channel intermediate-conductance Ca-activated blocker | 0.082 0.016 DBMET01477 0.075 0.022 DBMET00137 | DBMET01477 | |
| 0.06 | 0.03 | 0.081 | Dihydroorotate oxidase inhibitor | 0.055 0.038 DBMET01476 0.081 0.01 DBMET01477 0.08 0.01 DBMET00137 | DBMET01477 | |
| 0.037 | 0.007 | 0.037 | Retinoic acid receptor agonist | 0.031 0.009 DBMET01477 | ||
| 0.065 | 0.035 | 0.152 | Carbonic anhydrase stimulant | 0.078 0.027 DBMET01476 0.152 0.011 DBMET01477 0.075 0.029 DBMET00137 | DBMET01477 | |
| 0.052 | 0.022 | 0.058 | Dihydroorotase inhibitor | 0.058 0.017 DBMET01477 0.049 0.026 DBMET00137 | DBMET01477 | |
| 0.036 | 0.006 | 0.118 | Prostaglandin EP4 agonist | 0.035 0.006 DBMET01476 0.118 0.003 DBMET01477 | DBMET01477 | |
| 0.033 | 0.004 | 0.049 | Retinoid X beta receptor antagonist | 0.03 0.004 DBMET01476 0.049 0.003 DBMET01477 0.024 0.008 DBMET00137 | DBMET01477 | |
| 0.035 | 0.006 | 0.038 | Hedgehog signaling activator | 0.026 0.024 DBMET01476 0.038 0.005 DBMET01477 0.036 0.006 DBMET00137 | DBMET01477 | |
| 0.055 | 0.027 | 0.064 | Metalloproteinase-3 inhibitor | 0.046 0.038 DBMET01476 0.064 0.022 DBMET01477 | DBMET01477 | |
| 0.036 | 0.008 | 0.062 | Thyroid hormone agonist | 0.032 0.01 DBMET01476 0.062 0.004 DBMET01477 | DBMET01477 | |
| 0.055 | 0.027 | 0.075 | Bombesin 2 receptor antagonist | 0.046 0.04 DBMET01476 0.075 0.018 DBMET01477 0.049 0.034 DBMET00137 | DBMET01477 | |
| 0.048 | 0.02 | 0.122 | NMDA receptor subunit 3A antagonist | 0.122 0.007 DBMET01477 | DBMET01477 | |
| 0.039 | 0.011 | 0.09 | Prostaglandin EP4 antagonist | 0.025 0.019 DBMET01476 0.09 0.005 DBMET01477 | DBMET01477 | |
| 0.03 | 0.003 | 0.135 | Glutamate (mGluR6) agonist | 0.039 0.003 DBMET01476 0.135 0.001 DBMET01477 0.019 0.004 DBMET00137 | DBMET01477 | |
| 0.034 | 0.007 | 0.062 | Leukotriene B4 receptor 2 antagonist | 0.02 0.018 DBMET01476 0.062 0.004 DBMET01477 | DBMET01477 | |
| 0.034 | 0.006 | 0.044 | Vanilloid 2 agonist | 0.03 0.01 DBMET01476 0.044 0.004 DBMET01477 0.037 0.005 DBMET00137 | DBMET01477 | |
| 0.043 | 0.017 | 0.043 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.031 | 0.005 | 0.397 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.041 0.004 DBMET01476 0.397 0.002 DBMET01477 | DBMET01477 | |
| 0.058 | 0.032 | 0.081 | Adenine nucleotide translocase inhibitor | 0.081 0.009 DBMET01477 | DBMET01477 | |
| 0.03 | 0.004 | 0.031 | Neuraminidase (Influenza B) inhibitor | 0.02 0.018 DBMET01476 0.031 0.004 DBMET01477 0.025 0.008 DBMET00137 | DBMET01477 | |
| 0.046 | 0.02 | 0.054 | Heme oxygenase inhibitor | 0.054 0.009 DBMET01477 0.05 0.013 DBMET00137 | DBMET01477 | |
| 0.03 | 0.004 | 0.03 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.028 0.005 DBMET01477 0.025 0.007 DBMET00137 | ||
| 0.039 | 0.014 | 0.124 | ATP citrate lysase inhibitor | 0.052 0.007 DBMET01476 0.124 0.003 DBMET01477 0.033 0.021 DBMET00137 | DBMET01477 | |
| 0.083 | 0.058 | 0.083 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.055 | 0.03 | 0.065 | Prolyl endopeptidase inhibitor | 0.051 0.035 DBMET01476 0.065 0.019 DBMET01477 0.053 0.032 DBMET00137 | DBMET01477 | |
| 0.047 | 0.022 | 0.058 | Angiotensin AT1 receptor antagonist | 0.058 0.008 DBMET01477 0.04 0.033 DBMET00137 | DBMET01477 | |
| 0.075 | 0.051 | 0.075 | Phosphodiesterase VI inhibitor | |||
| 0.084 | 0.06 | 0.101 | Androgen antagonist | 0.101 0.046 DBMET01477 | DBMET01477 | |
| 0.141 | 0.117 | 0.219 | 3C-like protease (Human coronavirus) inhibitor | 0.167 0.078 DBMET01476 0.17 0.074 DBMET01477 0.219 0.042 DBMET00137 | DBMET00137 | |
| 0.043 | 0.02 | 0.049 | MAP3K5 inhibitor | 0.049 0.013 DBMET01477 0.037 0.03 DBMET00137 | DBMET01477 | |
| 0.038 | 0.015 | 0.038 | Melatonin receptor 1A agonist | 0.034 0.022 DBMET01477 0.037 0.018 DBMET00137 | ||
| 0.069 | 0.045 | 0.106 | Acetylcholine M5 receptor agonist | 0.062 0.053 DBMET01477 0.106 0.017 DBMET00137 | DBMET00137 | |
| 0.056 | 0.033 | 0.069 | Immunoglobulin Fc receptor antagonist | 0.065 0.017 DBMET01477 0.069 0.012 DBMET00137 | DBMET00137 | |
| 0.046 | 0.024 | 0.122 | Kainate receptor antagonist | 0.042 0.027 DBMET01476 0.122 0.005 DBMET01477 | DBMET01477 | |
| 0.062 | 0.039 | 0.064 | Cyclin D1 inhibitor | 0.064 0.036 DBMET00137 | DBMET00137 | |
| 0.038 | 0.015 | 0.051 | Carboxypeptidase B inhibitor | 0.037 0.016 DBMET01476 0.051 0.006 DBMET01477 0.031 0.027 DBMET00137 | DBMET01477 | |
| 0.027 | 0.005 | 0.027 | Toll-Like receptor 8 agonist | 0.019 0.018 DBMET01477 | ||
| 0.026 | 0.004 | 0.032 | Methylmalonyl-CoA mutase inhibitor | 0.032 0.002 DBMET01476 0.032 0.002 DBMET01477 0.023 0.005 DBMET00137 | DBMET01477 | |
| 0.032 | 0.01 | 0.045 | Nicotinic acid receptor 2 antagonist | 0.027 0.018 DBMET01476 0.045 0.004 DBMET01477 0.037 0.006 DBMET00137 | DBMET01477 | |
| 0.034 | 0.012 | 0.047 | Purinergic P2Y15 antagonist | 0.029 0.019 DBMET01476 0.042 0.006 DBMET01477 0.047 0.004 DBMET00137 | DBMET00137 | |
| 0.044 | 0.022 | 0.102 | Urate transporter 1 inhibitor | 0.048 0.02 DBMET01476 0.102 0.005 DBMET01477 | DBMET01477 | |
| 0.043 | 0.022 | 0.123 | AMPA 4 receptor antagonist | 0.046 0.018 DBMET01476 0.123 0.004 DBMET01477 0.039 0.028 DBMET00137 | DBMET01477 | |
| 0.029 | 0.007 | 0.03 | Retinoic acid gamma receptor agonist | 0.03 0.006 DBMET01477 | DBMET01477 | |
| 0.108 | 0.086 | 0.129 | Transcription factor STAT6 inhibitor | 0.129 0.045 DBMET01477 0.124 0.054 DBMET00137 | DBMET01477 | |
| 0.034 | 0.013 | 0.139 | Kynurenine 3 monooxygenase inhibitor | 0.05 0.006 DBMET01476 0.139 0.003 DBMET01477 | DBMET01477 | |
| 0.096 | 0.076 | 0.102 | Beta glucuronidase inhibitor | 0.102 0.067 DBMET01477 0.099 0.071 DBMET00137 | DBMET01477 | |
| 0.03 | 0.009 | 0.101 | 5-Alpha-reductase 2 inhibitor | 0.019 0.014 DBMET01476 0.101 0.005 DBMET01477 | DBMET01477 | |
| 0.031 | 0.011 | 0.045 | Retinoid X gamma receptor antagonist | 0.031 0.011 DBMET01476 0.045 0.004 DBMET01477 | DBMET01477 | |
| 0.027 | 0.008 | 0.051 | Lysophosphatidic acid 1 receptor antagonist | 0.025 0.01 DBMET01476 0.051 0.004 DBMET01477 | DBMET01477 | |
| 0.104 | 0.085 | 0.104 | Acetylcholine muscarinic antagonist | 0.099 0.092 DBMET01477 | ||
| 0.024 | 0.005 | 0.026 | Antibiotic Anthracycline-like | 0.018 0.016 DBMET01476 0.026 0.004 DBMET01477 0.023 0.007 DBMET00137 | DBMET01477 | |
| 0.059 | 0.04 | 0.124 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.055 0.046 DBMET01476 0.124 0.011 DBMET01477 0.054 0.047 DBMET00137 | DBMET01477 | |
| 0.023 | 0.004 | 0.037 | Carbonic anhydrase XI inhibitor | 0.019 0.004 DBMET01476 0.037 0.002 DBMET01477 0.018 0.005 DBMET00137 | DBMET01477 | |
| 0.023 | 0.005 | 0.029 | Telomerase stimulant | 0.02 0.007 DBMET01476 0.029 0.003 DBMET01477 0.025 0.004 DBMET00137 | DBMET01477 | |
| 0.063 | 0.044 | 0.063 | Carbonic anhydrase inhibitor | |||
| 0.025 | 0.006 | 0.043 | Ileal bile acid transport inhibitor | 0.043 0.004 DBMET01477 | DBMET01477 | |
| 0.041 | 0.023 | 0.145 | VCAM-1 antagonist | 0.077 0.005 DBMET01476 0.145 0.004 DBMET01477 | DBMET01477 | |
| 0.081 | 0.063 | 0.081 | Histamine H2 receptor antagonist | 0.076 0.074 DBMET00137 | ||
| 0.046 | 0.028 | 0.046 | Beta adrenoreceptor agonist | 0.045 0.032 DBMET01477 | ||
| 0.041 | 0.023 | 0.147 | VCAM antagonist | 0.077 0.005 DBMET01476 0.147 0.004 DBMET01477 | DBMET01477 | |
| 0.037 | 0.021 | 0.061 | Tryptophan 5 hydroxylase inhibitor | 0.041 0.013 DBMET01476 0.061 0.004 DBMET01477 0.041 0.013 DBMET00137 | DBMET01477 | |
| 0.113 | 0.096 | 0.118 | Alkaline phosphatase inhibitor | 0.118 0.089 DBMET01477 | DBMET01477 | |
| 0.029 | 0.013 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.012 DBMET01477 | DBMET01477 | |
| 0.111 | 0.095 | 0.111 | Nav1.2 sodium channel blocker | |||
| 0.029 | 0.014 | 0.029 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.019 DBMET01477 0.025 0.021 DBMET00137 | ||
| 0.059 | 0.043 | 0.085 | Collagenase 3 inhibitor | 0.085 0.021 DBMET01477 | DBMET01477 | |
| 0.029 | 0.014 | 0.031 | Glucosylceramidase stimulant | 0.026 0.024 DBMET01477 0.031 0.011 DBMET00137 | DBMET00137 | |
| 0.038 | 0.023 | 0.076 | Integrin alpha2 antagonist | 0.044 0.016 DBMET01476 0.076 0.005 DBMET01477 0.038 0.023 DBMET00137 | DBMET01477 | |
| 0.059 | 0.044 | 0.059 | Cannabinoid CB1 receptor agonist | |||
| 0.027 | 0.013 | 0.367 | Prostaglandin D2 antagonist | 0.041 0.008 DBMET01476 0.367 0.003 DBMET01477 | DBMET01477 | |
| 0.05 | 0.036 | 0.05 | Factor III inhibitor | |||
| 0.018 | 0.004 | 0.018 | DNA polymerase III polC-type inhibitor | |||
| 0.041 | 0.028 | 0.05 | Liver X receptor alpha agonist | 0.05 0.019 DBMET01477 | DBMET01477 | |
| 0.043 | 0.03 | 0.065 | Leukocyte elastase inhibitor | 0.043 0.03 DBMET01476 0.065 0.016 DBMET01477 | DBMET01477 | |
| 0.025 | 0.012 | 0.027 | ICAM 1 antagonist | 0.027 0.009 DBMET01477 | DBMET01477 | |
| 0.027 | 0.015 | 0.027 | Sodium/glucose cotransporter inhibitor | 0.025 0.02 DBMET01477 0.024 0.023 DBMET00137 | ||
| 0.024 | 0.012 | 0.08 | Integrin alpha4beta7 antagonist | 0.08 0.004 DBMET01477 | DBMET01477 | |
| 0.035 | 0.023 | 0.048 | Angiotensin II receptor antagonist | 0.048 0.008 DBMET01477 | DBMET01477 | |
| 0.062 | 0.05 | 0.073 | Calcium channel P-type blocker | 0.068 0.032 DBMET01477 0.073 0.022 DBMET00137 | DBMET00137 | |
| 0.024 | 0.012 | 0.024 | Vitamin D receptor antagonist | |||
| 0.014 | 0.003 | 0.014 | Mannitol 2-dehydrogenase inhibitor | |||
| 0.018 | 0.008 | 0.02 | Purinergic P2Y1 agonist | 0.015 0.012 DBMET01476 0.02 0.007 DBMET01477 0.019 0.007 DBMET00137 | DBMET01477 | |
| 0.021 | 0.011 | 0.034 | Caspase 8 inhibitor | 0.034 0.004 DBMET01476 0.034 0.004 DBMET01477 | DBMET01477 | |
| 0.031 | 0.021 | 0.035 | Elastase 3A inhibitor | 0.03 0.023 DBMET01476 0.035 0.013 DBMET01477 | DBMET01477 | |
| 0.031 | 0.021 | 0.035 | Elastase 3B inhibitor | 0.03 0.023 DBMET01476 0.035 0.013 DBMET01477 | DBMET01477 | |
| 0.031 | 0.021 | 0.035 | Elastase 2B inhibitor | 0.03 0.023 DBMET01476 0.035 0.013 DBMET01477 | DBMET01477 | |
| 0.035 | 0.025 | 0.069 | p53 inhibitor | 0.069 0.005 DBMET01477 | DBMET01477 | |
| 0.017 | 0.007 | 0.022 | Integrin alphaVbeta6 antagonist | 0.022 0.005 DBMET01477 | DBMET01477 | |
| 0.012 | 0.003 | 0.012 | DNA polymerase III subunit alpha inhibitor | 0.007 0.004 DBMET01477 | ||
| 0.027 | 0.017 | 0.043 | Integrin alpha2beta1 antagonist | 0.043 0.005 DBMET01477 0.028 0.015 DBMET00137 | DBMET01477 | |
| 0.028 | 0.018 | 0.066 | NMDA 2D receptor antagonist | 0.066 0.005 DBMET01477 | DBMET01477 | |
| 0.039 | 0.031 | 0.134 | Integrin alpha5beta1 antagonist | 0.042 0.026 DBMET01476 0.134 0.005 DBMET01477 | DBMET01477 | |
| 0.052 | 0.043 | 0.07 | Matrix metalloproteinase (membrane-type) inhibitor | 0.07 0.025 DBMET01477 | DBMET01477 | |
| 0.019 | 0.011 | 0.045 | Aminopeptidase A inhibitor | 0.025 0.008 DBMET01476 0.045 0.004 DBMET01477 | DBMET01477 | |
| 0.013 | 0.006 | 0.013 | Purine nucleoside phosphorylase inhibitor | 0.013 0.006 DBMET01477 | ||
| 0.026 | 0.018 | 0.031 | Thymidine phosphorylase inhibitor | 0.028 0.015 DBMET01477 0.031 0.011 DBMET00137 | DBMET00137 | |
| 0.101 | 0.094 | 0.101 | MAP kinase kinase inhibitor | |||
| 0.017 | 0.01 | 0.099 | Thyroid hormone alpha antagonist | 0.099 0.004 DBMET01477 | DBMET01477 | |
| 0.022 | 0.015 | 0.062 | Peroxisome proliferator-activated receptor alpha antagonist | 0.062 0.007 DBMET01477 | DBMET01477 | |
| 0.019 | 0.012 | 0.024 | Retinoic acid receptor antagonist | 0.024 0.008 DBMET01477 | DBMET01477 | |
| 0.077 | 0.07 | 0.15 | NMDA receptor antagonist | 0.15 0.024 DBMET01477 | DBMET01477 | |
| 0.046 | 0.04 | 0.076 | HCV NS3/NS4A protease inhibitor | 0.067 0.016 DBMET01476 0.076 0.012 DBMET01477 0.049 0.033 DBMET00137 | DBMET01477 | |
| 0.019 | 0.013 | 0.139 | Integrin alphaVbeta1 antagonist | 0.023 0.009 DBMET01476 0.139 0.003 DBMET01477 | DBMET01477 | |
| 0.084 | 0.078 | 0.091 | Protein kinase C zeta inhibitor | 0.091 0.064 DBMET01477 0.082 0.081 DBMET00137 | DBMET01477 | |
| 0.04 | 0.034 | 0.155 | Glutamate (mGluR group III) agonist | 0.052 0.022 DBMET01476 0.155 0.005 DBMET01477 0.041 0.033 DBMET00137 | DBMET01477 | |
| 0.031 | 0.025 | 0.048 | Methionyl aminopeptidase 1 inhibitor | 0.048 0.007 DBMET01477 0.033 0.021 DBMET00137 | DBMET01477 | |
| 0.046 | 0.04 | 0.069 | Topoisomerase II beta inhibitor | 0.069 0.017 DBMET01477 0.055 0.027 DBMET00137 | DBMET01477 | |
| 0.02 | 0.014 | 0.027 | Retinoic acid alpha receptor antagonist | 0.027 0.008 DBMET01477 | DBMET01477 | |
| 0.031 | 0.026 | 0.033 | Liver X receptor beta agonist | 0.033 0.023 DBMET01477 | DBMET01477 | |
| 0.032 | 0.027 | 0.057 | RNA-directed RNA polymerase inhibitor | 0.057 0.01 DBMET01477 | DBMET01477 | |
| 0.014 | 0.008 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.02 0.004 DBMET01477 0.02 0.004 DBMET00137 | DBMET00137 | |
| 0.028 | 0.023 | 0.056 | Peptide deformylase inhibitor | 0.029 0.022 DBMET01476 0.056 0.008 DBMET01477 0.03 0.021 DBMET00137 | DBMET01477 | |
| 0.027 | 0.022 | 0.055 | Liver X receptor beta antagonist | 0.055 0.007 DBMET01477 | DBMET01477 | |
| 0.059 | 0.055 | 0.083 | Matrix metalloproteinase inhibitor | 0.083 0.035 DBMET01477 | DBMET01477 | |
| 0.093 | 0.088 | 0.306 | Factor V inhibitor | 0.306 0.002 DBMET01476 0.144 0.021 DBMET01477 | DBMET01476 | |
| 0.096 | 0.092 | 0.096 | Electron transport complex I inhibitor | |||
| 0.029 | 0.025 | 0.161 | Caspase 2 inhibitor | 0.142 0.004 DBMET01476 0.161 0.003 DBMET01477 | DBMET01477 | |
| 0.095 | 0.091 | 0.095 | CDC-like kinase 3 inhibitor | |||
| 0.07 | 0.066 | 0.12 | Metalloproteinase-2 inhibitor | 0.072 0.062 DBMET01476 0.12 0.029 DBMET01477 | DBMET01477 | |
| 0.012 | 0.009 | 0.031 | Calcium-dependent phospholipase A2 inhibitor | 0.031 0.004 DBMET01477 | DBMET01477 | |
| 0.008 | 0.005 | 0.175 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.175 0.001 DBMET01476 0.045 0.002 DBMET01477 | DBMET01476 | |
| 0.01 | 0.007 | 0.02 | Integrin alphaVbeta5 antagonist | 0.02 0.004 DBMET01477 | DBMET01477 | |
| 0.013 | 0.01 | 0.014 | Cyclin D2 inhibitor | 0.014 0.007 DBMET00137 | DBMET00137 | |
| 0.012 | 0.009 | 0.018 | Integrin beta2 antagonist | 0.018 0.005 DBMET01477 | DBMET01477 | |
| 0.031 | 0.029 | 0.097 | Glutamate (mGluR4) agonist | 0.039 0.017 DBMET01476 0.097 0.004 DBMET01477 0.032 0.029 DBMET00137 | DBMET01477 | |
| 0.022 | 0.02 | 0.032 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.032 0.007 DBMET01477 0.023 0.017 DBMET00137 | DBMET01477 | |
| 0.085 | 0.084 | 0.096 | Topoisomerase I inhibitor | 0.096 0.073 DBMET01477 | DBMET01477 | |
| 0.021 | 0.019 | 0.102 | Retinoid X gamma receptor agonist | 0.028 0.012 DBMET01476 0.102 0.004 DBMET01477 | DBMET01477 | |
| 0.086 | 0.085 | 0.113 | Nitric-oxide synthase inhibitor | 0.113 0.043 DBMET01477 | DBMET01477 | |
| 0.019 | 0.018 | 0.021 | Corticosteroid-like | 0.021 0.015 DBMET01477 | DBMET01477 | |
| 0.016 | 0.015 | 0.028 | Nicotinic acid receptor 1 antagonist | 0.028 0.005 DBMET01477 0.022 0.007 DBMET00137 | DBMET01477 | |
| 0.024 | 0.023 | 0.044 | Calcium-sensing receptor agonist | 0.044 0.006 DBMET01477 | DBMET01477 | |
| 0.019 | 0.018 | 0.1 | Retinoid X beta receptor agonist | 0.025 0.011 DBMET01476 0.1 0.003 DBMET01477 | DBMET01477 | |
| 0.042 | 0.042 | 0.049 | CC chemokine 4 receptor antagonist | 0.049 0.028 DBMET01477 0.048 0.031 DBMET00137 | DBMET01477 | |
| 0.006 | 0.005 | 0.016 | Integrin alpha5beta6 antagonist | 0.008 0.004 DBMET01476 0.016 0.002 DBMET01477 0.006 0.005 DBMET00137 | DBMET01477 | |
| 0.018 | 0.017 | 0.077 | Kainate receptor 1 antagonist | 0.023 0.013 DBMET01476 0.077 0.004 DBMET01477 | DBMET01477 | |
| 0.049 | 0.05 | 0.092 | Angiotensin-converting enzyme inhibitor | 0.092 0.01 DBMET01477 | DBMET01477 | |
| 0.013 | 0.013 | 0.025 | Integrin alpha4beta1 antagonist | 0.025 0.008 DBMET01477 | DBMET01477 | |
| 0.023 | 0.024 | 0.031 | Acid ceramidase inhibitor | 0.031 0.008 DBMET00137 | DBMET00137 | |
| 0.038 | 0.039 | 0.069 | Nerve growth factor antagonist | 0.046 0.024 DBMET01476 0.069 0.005 DBMET01477 0.06 0.01 DBMET00137 | DBMET01477 | |
| 0.075 | 0.076 | 0.093 | Thioredoxin reductase inhibitor | 0.093 0.036 DBMET01476 0.085 0.049 DBMET01477 | DBMET01476 | |
| 0.04 | 0.042 | 0.049 | Microtubule stabilization | 0.049 0.03 DBMET01477 | DBMET01477 | |
| 0.007 | 0.009 | 0.018 | Thyroid hormone beta agonist | 0.018 0.004 DBMET01477 | DBMET01477 | |
| 0.033 | 0.036 | 0.051 | Glutamate (mGluR group II) antagonist | 0.051 0.015 DBMET01477 | DBMET01477 | |
| 0.083 | 0.086 | 0.114 | Urease inhibitor | 0.114 0.051 DBMET01477 0.102 0.064 DBMET00137 | DBMET01477 | |
| 0.073 | 0.076 | 0.118 | Inducible nitric-oxide synthase inhibitor | 0.118 0.026 DBMET01477 0.074 0.073 DBMET00137 | DBMET01477 | |
| 0.008 | 0.012 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.008 DBMET00137 | DBMET00137 | |
| 0.056 | 0.06 | 0.058 | Phosphodiesterase 1C inhibitor | 0.058 0.053 DBMET00137 | DBMET00137 | |
| 0.055 | 0.059 | 0.098 | CDC25B inhibitor | 0.098 0.016 DBMET01476 0.094 0.018 DBMET01477 | DBMET01476 | |
| 0.026 | 0.031 | 0.051 | Epoxide hydrolase 1 inhibitor | 0.028 0.026 DBMET01476 0.051 0.005 DBMET01477 0.037 0.014 DBMET00137 | DBMET01477 | |
| 0.032 | 0.036 | 0.037 | Adenosine uptake inhibitor | 0.037 0.017 DBMET00137 | DBMET00137 | |
| 0.035 | 0.04 | 0.096 | Integrin alpha1beta1 antagonist | 0.052 0.006 DBMET01476 0.096 0.003 DBMET01477 | DBMET01477 | |
| 0.041 | 0.046 | 0.047 | Cholesterol esterase inhibitor | 0.047 0.034 DBMET01477 0.046 0.036 DBMET00137 | DBMET01477 | |
| 0.023 | 0.028 | 0.037 | Nicotinic alpha4beta2 receptor agonist | 0.037 0.01 DBMET00137 | DBMET00137 | |
| 0.108 | 0.114 | 0.142 | Nav1.6 sodium channel blocker | 0.132 0.078 DBMET01477 0.142 0.063 DBMET00137 | DBMET00137 | |
| 0.037 | 0.043 | 0.072 | Oleamide hydrolase inhibitor | 0.072 0.015 DBMET01476 0.039 0.038 DBMET01477 | DBMET01476 | |
| 0.031 | 0.038 | 0.169 | Cholecystokinin B agonist | 0.043 0.021 DBMET01476 0.169 0.005 DBMET01477 | DBMET01477 | |
| 0.008 | 0.015 | 0.011 | Calcineurin inhibitor | 0.011 0.008 DBMET01477 | DBMET01477 | |
| 0.009 | 0.016 | 0.02 | Angiotensin AT1B receptor antagonist | 0.02 0.006 DBMET01477 | DBMET01477 | |
| 0.007 | 0.014 | 0.015 | Carboxypeptidase B2 inhibitor | 0.015 0.005 DBMET01477 | DBMET01477 | |
| 0.034 | 0.041 | 0.257 | Macrophage elastase inhibitor | 0.057 0.02 DBMET01476 0.257 0.004 DBMET01477 | DBMET01477 | |
| 0.03 | 0.038 | 0.04 | Diamine oxidase inhibitor | 0.04 0.023 DBMET00137 | DBMET00137 | |
| 0.014 | 0.022 | 0.08 | Neutral endopeptidase inhibitor | 0.032 0.011 DBMET01476 0.08 0.005 DBMET01477 | DBMET01477 | |
| 0.036 | 0.044 | 0.041 | CF transmembrane conductance regulator antagonist | 0.041 0.024 DBMET00137 | DBMET00137 | |
| 0.029 | 0.037 | 0.052 | Inosine monophosphate dehydrogenase inhibitor | 0.052 0.014 DBMET01477 | DBMET01477 | |
| 0.049 | 0.058 | 0.071 | Botulinum neurotoxin type A inhibitor | 0.071 0.024 DBMET01477 0.054 0.048 DBMET00137 | DBMET01477 | |
| 0.03 | 0.038 | 0.038 | Factor XIIIa inhibitor | 0.038 0.025 DBMET01477 | DBMET01477 | |
| 0.075 | 0.084 | 0.102 | CC chemokine 5 receptor agonist | 0.098 0.024 DBMET01477 0.102 0.019 DBMET00137 | DBMET00137 | |
| 0.021 | 0.03 | 0.074 | AMPA 3 receptor antagonist | 0.029 0.021 DBMET01476 0.074 0.005 DBMET01477 | DBMET01477 | |
| 0.012 | 0.021 | 0.037 | Integrin beta6 antagonist | 0.018 0.005 DBMET01476 0.037 0.002 DBMET01477 | DBMET01477 | |
| 0.066 | 0.075 | 0.084 | Potassium channel (Tandem pore domain) blocker | 0.075 0.047 DBMET01477 0.084 0.026 DBMET00137 | DBMET00137 | |
| 0.057 | 0.066 | 0.084 | Sirtuin 1 inhibitor | 0.084 0.032 DBMET01477 | DBMET01477 | |
| 0.024 | 0.034 | 0.043 | HCV NS5B polymerase inhibitor | 0.043 0.012 DBMET01477 | DBMET01477 | |
| 0.034 | 0.044 | 0.151 | Glucagon-like peptide 1 receptor antagonist | 0.037 0.033 DBMET01476 0.151 0.004 DBMET01477 | DBMET01477 | |
| 0.023 | 0.034 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.021 DBMET01477 | DBMET01477 | |
| 0.012 | 0.024 | 0.02 | Cyclin T1 inhibitor | 0.02 0.011 DBMET00137 | DBMET00137 | |
| 0.037 | 0.048 | 0.075 | Guanylate cyclase stimulant | 0.075 0.01 DBMET01477 | DBMET01477 | |
| 0.014 | 0.026 | 0.021 | CXC chemokine 5 receptor antagonist | 0.021 0.007 DBMET01477 | DBMET01477 | |
| 0.012 | 0.025 | 0.037 | Thyroid hormone alpha agonist | 0.016 0.012 DBMET01476 0.037 0.004 DBMET01477 | DBMET01477 | |
| 0.058 | 0.07 | 0.076 | Amidase inhibitor | 0.064 0.059 DBMET01476 0.076 0.042 DBMET01477 | DBMET01477 | |
| 0.013 | 0.026 | 0.032 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.032 0.007 DBMET01477 | DBMET01477 | |
| 0.019 | 0.032 | 0.029 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.029 0.018 DBMET01477 | DBMET01477 | |
| 0.099 | 0.112 | 0.109 | Cytokine production inhibitor | 0.109 0.101 DBMET01477 | DBMET01477 | |
| 0.014 | 0.027 | 0.27 | Vitronectin receptor antagonist | 0.025 0.012 DBMET01476 0.27 0.003 DBMET01477 | DBMET01477 | |
| 0.016 | 0.029 | 0.022 | Geranylgeranyltransferase inhibitor | 0.022 0.016 DBMET01477 | DBMET01477 | |
| 0.011 | 0.024 | 0.277 | Endothelin B receptor antagonist | 0.277 0.003 DBMET01476 0.031 0.009 DBMET01477 | DBMET01476 | |
| 0.038 | 0.051 | 0.208 | Prostaglandin E2 antagonist | 0.208 0.005 DBMET01477 | DBMET01477 | |
| 0.083 | 0.097 | 0.115 | Protein kinase (CK2) alpha inhibitor | 0.115 0.066 DBMET01477 | DBMET01477 | |
| 0.025 | 0.04 | 0.058 | Caspase 6 inhibitor | 0.057 0.004 DBMET01476 0.058 0.004 DBMET01477 | DBMET01477 | |
| 0.03 | 0.045 | 0.041 | Delayed rectifier potassium channel blocker | 0.041 0.019 DBMET00137 | DBMET00137 | |
| 0.028 | 0.043 | 0.037 | Protein kinase (CK2) beta inhibitor | 0.034 0.022 DBMET01477 0.037 0.016 DBMET00137 | DBMET00137 | |
| 0.019 | 0.034 | 0.027 | CXC chemokine 2 receptor antagonist | 0.027 0.018 DBMET01477 | DBMET01477 | |
| 0.061 | 0.077 | 0.09 | Metalloproteinase-9 inhibitor | 0.09 0.038 DBMET01477 | DBMET01477 | |
| 0.099 | 0.116 | 0.291 | NADPH oxidase inhibitor | 0.291 0.014 DBMET01476 0.143 0.059 DBMET01477 | DBMET01476 | |
| 0.033 | 0.05 | 0.07 | Histamine H2 receptor agonist | 0.045 0.027 DBMET01477 0.07 0.01 DBMET00137 | DBMET00137 | |
| 0.033 | 0.051 | 0.044 | Carbonic anhydrase VII inhibitor | 0.044 0.036 DBMET01477 | DBMET01477 | |
| 0.013 | 0.032 | 0.018 | Complement factor D inhibitor | 0.018 0.012 DBMET00137 | DBMET00137 | |
| 0.011 | 0.03 | 0.016 | Nicotinic alpha4 receptor agonist | 0.016 0.011 DBMET00137 | DBMET00137 | |
| 0.058 | 0.077 | 0.13 | HIV-1 integrase inhibitor | 0.13 0.012 DBMET01477 | DBMET01477 | |
| 0.015 | 0.034 | 0.196 | Integrin alphaVbeta3 antagonist | 0.03 0.008 DBMET01476 0.196 0.003 DBMET01477 | DBMET01477 | |
| 0.059 | 0.078 | 0.122 | Glutamate receptor agonist | 0.122 0.026 DBMET01477 | DBMET01477 | |
| 0.008 | 0.028 | 0.029 | Egl nine homolog 1 inhibitor | 0.029 0.004 DBMET01477 | DBMET01477 | |
| 0.026 | 0.046 | 0.092 | Complement C3a chemotactic receptor antagonist | 0.092 0.01 DBMET01477 | DBMET01477 | |
| 0.018 | 0.038 | 0.083 | Glucagon receptor antagonist | 0.083 0.005 DBMET01477 | DBMET01477 | |
| 0.042 | 0.062 | 0.113 | HIV-1 integrase (Strand Transfer) inhibitor | 0.094 0.025 DBMET01476 0.113 0.018 DBMET01477 | DBMET01477 | |
| 0.01 | 0.031 | 0.085 | Integrin beta7 antagonist | 0.085 0.004 DBMET01477 | DBMET01477 | |
| 0.018 | 0.039 | 0.259 | Endothelin receptor antagonist | 0.259 0.003 DBMET01476 0.065 0.008 DBMET01477 | DBMET01476 | |
| 0.165 | 0.187 | 0.243 | Transcription factor STAT3 inhibitor | 0.243 0.089 DBMET01477 0.184 0.158 DBMET00137 | DBMET01477 | |
| 0.045 | 0.068 | 0.111 | DNA helicase inhibitor | 0.064 0.022 DBMET01476 0.111 0.004 DBMET01477 | DBMET01477 | |
| 0.014 | 0.038 | 0.074 | AMPA 1 receptor antagonist | 0.074 0.008 DBMET01477 | DBMET01477 | |
| 0.021 | 0.045 | 0.028 | Glutamate (mGluR2) antagonist | 0.028 0.024 DBMET01477 | DBMET01477 | |
| 0.01 | 0.035 | 0.387 | Integrin beta3 antagonist | 0.019 0.014 DBMET01476 0.387 0.004 DBMET01477 | DBMET01477 | |
| 0.138 | 0.163 | 0.188 | Histone acetyltransferase inhibitor | 0.188 0.087 DBMET01477 0.161 0.125 DBMET00137 | DBMET01477 | |
| 0.057 | 0.082 | 0.073 | Secretase beta inhibitor | 0.073 0.045 DBMET01477 0.065 0.058 DBMET00137 | DBMET01477 | |
| 0.02 | 0.045 | 0.033 | Complement factor 1s inhibitor | 0.028 0.01 DBMET01477 0.033 0.005 DBMET00137 | DBMET00137 | |
| 0.006 | 0.031 | 0.025 | Immunosuppressant Cyclosporine-like | 0.025 0.002 DBMET01476 | DBMET01476 | |
| 0.032 | 0.057 | 0.096 | NMDA 2A receptor antagonist | 0.096 0.014 DBMET01477 | DBMET01477 | |
| 0.004 | 0.029 | 0.009 | DNA topoisomerase III inhibitor | 0.009 0.004 DBMET00137 | DBMET00137 | |
| 0.006 | 0.032 | 0.019 | Egl nine homolog 3 inhibitor | 0.019 0.004 DBMET01477 | DBMET01477 | |
| 0.05 | 0.076 | 0.059 | Phosphodiesterase 1A inhibitor | 0.059 0.044 DBMET00137 | DBMET00137 | |
| 0.114 | 0.14 | 0.141 | Neuropeptide Y1 antagonist | 0.122 0.118 DBMET01476 0.141 0.08 DBMET01477 0.126 0.108 DBMET00137 | DBMET01477 | |
| 0.011 | 0.038 | 0.147 | VLA-4 antagonist | 0.071 0.009 DBMET01476 0.147 0.004 DBMET01477 | DBMET01477 | |
| 0.016 | 0.044 | 0.203 | Prostaglandin EP3 antagonist | 0.034 0.018 DBMET01476 0.203 0.004 DBMET01477 | DBMET01477 | |
| 0.05 | 0.077 | 0.078 | Corticotropin releasing factor 2 receptor antagonist | 0.078 0.019 DBMET01477 0.076 0.021 DBMET00137 | DBMET01477 | |
| 0.004 | 0.032 | 0.01 | Neurokinin 3 agonist | 0.01 0.009 DBMET01477 | DBMET01477 | |
| 0.024 | 0.053 | 0.045 | Histone deacetylase 7 inhibitor | 0.045 0.02 DBMET01476 0.033 0.03 DBMET01477 | DBMET01476 | |
| 0.041 | 0.07 | 0.057 | Autotaxin inhibitor | 0.057 0.031 DBMET01477 | DBMET01477 | |
| 0.026 | 0.055 | 0.07 | Erythropoietin receptor agonist | 0.07 0.014 DBMET01477 | DBMET01477 | |
| 0.124 | 0.154 | 0.175 | I kappa B kinase epsilon inhibitor | 0.175 0.094 DBMET00137 | DBMET00137 | |
| 0.008 | 0.038 | 0.013 | Integrin alphaLbeta2 antagonist | 0.013 0.01 DBMET01477 | DBMET01477 | |
| 0.011 | 0.042 | 0.036 | Endothelin A receptor antagonist | 0.036 0.009 DBMET01477 | DBMET01477 | |
| 0.013 | 0.044 | 0.035 | NMDA receptor glycine site antagonist | 0.035 0.01 DBMET01477 | DBMET01477 | |
| 0.016 | 0.049 | 0.03 | Acetylcholine M4 receptor agonist | 0.03 0.022 DBMET00137 | DBMET00137 | |
| 0.044 | 0.078 | 0.105 | HIV-1 integrase (3'-Processing) inhibitor | 0.089 0.03 DBMET01476 0.105 0.024 DBMET01477 | DBMET01477 | |
| 0.005 | 0.039 | 0.012 | Free fatty acid receptor 2 antagonist | 0.012 0.004 DBMET01477 | DBMET01477 | |
| 0.012 | 0.046 | 0.149 | Integrin beta5 antagonist | 0.022 0.013 DBMET01476 0.149 0.004 DBMET01477 | DBMET01477 | |
| 0.029 | 0.064 | 0.041 | Histone deacetylase 9 inhibitor | 0.041 0.025 DBMET01476 | DBMET01476 | |
| 0.009 | 0.045 | 0.019 | Angiotensin-converting enzyme 2 inhibitor | 0.019 0.01 DBMET01477 | DBMET01477 | |
| 0.036 | 0.072 | 0.05 | GABA receptor antagonist | 0.05 0.045 DBMET01477 | DBMET01477 | |
| 0.04 | 0.078 | 0.061 | Cyclin-dependent kinase 6 inhibitor | 0.061 0.04 DBMET00137 | DBMET00137 | |
| 0.023 | 0.061 | 0.036 | Growth factor receptor-bound protein 2 antagonist | 0.036 0.021 DBMET01477 | DBMET01477 | |
| 0.06 | 0.1 | 0.128 | Chymotrypsin inhibitor | 0.128 0.023 DBMET01476 0.105 0.033 DBMET01477 | DBMET01476 | |
| 0.123 | 0.164 | 0.232 | Anticonvulsant | 0.232 0.064 DBMET01477 | DBMET01477 | |
| 0.03 | 0.071 | 0.047 | Carbonic anhydrase I inhibitor | 0.047 0.046 DBMET01477 | DBMET01477 | |
| 0.007 | 0.049 | 0.067 | Prostaglandin EP1 antagonist | 0.067 0.005 DBMET01477 | DBMET01477 | |
| 0.027 | 0.07 | 0.041 | Neurokinin 2 agonist | 0.041 0.029 DBMET01477 | DBMET01477 | |
| 0.013 | 0.056 | 0.025 | Protease (Human cytomegalovirus) inhibitor | 0.022 0.016 DBMET01477 0.025 0.011 DBMET00137 | DBMET00137 | |
| 0.035 | 0.078 | 0.058 | Potassium channel (ATP-sensitive) activator | 0.05 0.03 DBMET01477 0.058 0.018 DBMET00137 | DBMET00137 | |
| 0.035 | 0.078 | 0.042 | Parathyroid hormone antagonist | 0.042 0.041 DBMET01477 | DBMET01477 | |
| 0.064 | 0.108 | 0.091 | Protein kinase (CK2) inhibitor | 0.091 0.072 DBMET01477 | DBMET01477 | |
| 0.036 | 0.08 | 0.061 | Potassium channel (Inward rectifier) activator | 0.053 0.031 DBMET01477 0.061 0.019 DBMET00137 | DBMET00137 | |
| 0.156 | 0.2 | 0.249 | 12-Lipoxygenase inhibitor | 0.249 0.11 DBMET01477 | DBMET01477 | |
| 0.028 | 0.072 | 0.056 | Neurotensin receptor antagonist | 0.056 0.025 DBMET01477 | DBMET01477 | |
| 0.021 | 0.066 | 0.032 | Dipeptidyl peptidase II inhibitor | 0.032 0.024 DBMET01477 0.03 0.026 DBMET00137 | DBMET01477 | |
| 0.162 | 0.208 | 0.238 | Transcription factor STAT inhibitor | 0.238 0.095 DBMET01477 | DBMET01477 | |
| 0.026 | 0.074 | 0.045 | Glutamate (mGluR group I) agonist | 0.045 0.036 DBMET01477 0.042 0.04 DBMET00137 | DBMET01477 | |
| 0.034 | 0.083 | 0.045 | Benzodiazepine antagonist | 0.045 0.039 DBMET00137 | DBMET00137 | |
| 0.022 | 0.071 | 0.078 | Endothelin-converting enzyme inhibitor | 0.078 0.018 DBMET01477 | DBMET01477 | |
| 0.156 | 0.205 | 0.224 | Thyroid hormone antagonist | 0.224 0.142 DBMET01477 | DBMET01477 | |
| 0.039 | 0.088 | 0.06 | Fatty acid synthase inhibitor | 0.06 0.036 DBMET01477 | DBMET01477 | |
| 0.009 | 0.058 | 0.037 | Kainate receptor 3 antagonist | 0.037 0.005 DBMET01477 | DBMET01477 | |
| 0.007 | 0.059 | 0.062 | Cholecystokinin agonist | 0.062 0.005 DBMET01477 | DBMET01477 | |
| 0.019 | 0.07 | 0.031 | MAP3K8 inhibitor | 0.031 0.017 DBMET00137 | DBMET00137 | |
| 0.014 | 0.067 | 0.028 | Endothelial nitric-oxide synthase inhibitor | 0.028 0.026 DBMET01477 | DBMET01477 | |
| 0.003 | 0.055 | 0.021 | Antibiotic Macrolide-like | 0.021 0.006 DBMET01476 | DBMET01476 | |
| 0.01 | 0.064 | 0.016 | CC chemokine 9 receptor antagonist | 0.016 0.015 DBMET00137 | DBMET00137 | |
| 0.021 | 0.076 | 0.046 | DNA gyrase subunit B inhibitor | 0.046 0.017 DBMET01477 | DBMET01477 | |
| 0.039 | 0.094 | 0.067 | Lipase inhibitor | 0.067 0.057 DBMET01476 | DBMET01476 | |
| 0.18 | 0.235 | 0.279 | 15-Lipoxygenase inhibitor | 0.279 0.144 DBMET01477 | DBMET01477 | |
| 0.026 | 0.083 | 0.038 | 5 Hydroxytryptamine 2B agonist | 0.038 0.028 DBMET00137 | DBMET00137 | |
| 0.03 | 0.087 | 0.058 | Histamine H1 receptor agonist | 0.043 0.032 DBMET01477 0.058 0.01 DBMET00137 | DBMET00137 | |
| 0.05 | 0.107 | 0.075 | Transcription factor RelA inhibitor | 0.063 0.046 DBMET01477 0.075 0.022 DBMET00137 | DBMET00137 | |
| 0.048 | 0.107 | 0.124 | CYP2A6 inhibitor | 0.091 0.04 DBMET01477 0.124 0.025 DBMET00137 | DBMET00137 | |
| 0.024 | 0.083 | 0.073 | AMPA receptor antagonist | 0.073 0.02 DBMET01477 | DBMET01477 | |
| 0.029 | 0.089 | 0.059 | Glutamate (mGluR1) antagonist | 0.059 0.04 DBMET01477 | DBMET01477 | |
| 0.013 | 0.073 | 0.023 | Factor XIII inhibitor | 0.023 0.01 DBMET00137 | DBMET00137 | |
| 0.041 | 0.102 | 0.079 | 5 Hydroxytryptamine 3 agonist | 0.079 0.028 DBMET00137 | DBMET00137 | |
| 0.011 | 0.072 | 0.018 | Alpha 2b adrenoreceptor agonist | 0.018 0.016 DBMET00137 | DBMET00137 | |
| 0.002 | 0.063 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.004 DBMET00137 | DBMET00137 | |
| 0.065 | 0.127 | 0.102 | Bromodomain-containing protein 2 inhibitor | 0.102 0.038 DBMET00137 | DBMET00137 | |
| 0.01 | 0.072 | 0.056 | Kainate receptor 4 antagonist | 0.056 0.006 DBMET01477 | DBMET01477 | |
| 0.008 | 0.07 | 0.057 | Kainate receptor 5 antagonist | 0.057 0.005 DBMET01477 | DBMET01477 | |
| 0.043 | 0.105 | 0.115 | Elastase 1 inhibitor | 0.115 0.013 DBMET01476 0.104 0.018 DBMET01477 | DBMET01476 | |
| 0.059 | 0.123 | 0.13 | Protease inhibitor | 0.13 0.041 DBMET01476 0.115 0.051 DBMET01477 | DBMET01476 | |
| 0.054 | 0.12 | 0.175 | ErbB-3 antagonist | 0.175 0.013 DBMET01477 | DBMET01477 | |
| 0.019 | 0.085 | 0.07 | Alpha 1d adrenoreceptor agonist | 0.041 0.025 DBMET01477 0.07 0.007 DBMET00137 | DBMET00137 | |
| 0.016 | 0.085 | 0.034 | Catechol O-methyltransferase inhibitor | 0.034 0.02 DBMET01477 | DBMET01477 | |
| 0.03 | 0.099 | 0.081 | Aminopeptidase microsomal inhibitor | 0.081 0.024 DBMET01477 | DBMET01477 | |
| 0.018 | 0.088 | 0.037 | Vascular adhesion protein 1 inhibitor | 0.037 0.03 DBMET00137 | DBMET00137 | |
| 0.024 | 0.095 | 0.039 | HCV polyprotein inhibitor | 0.039 0.013 DBMET01477 | DBMET01477 | |
| 0.149 | 0.221 | 0.261 | Hypoxia-inducible factor 1 alpha inhibitor | 0.202 0.15 DBMET01476 0.261 0.091 DBMET01477 | DBMET01477 | |
| 0.115 | 0.188 | 0.19 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.19 0.106 DBMET01477 0.161 0.13 DBMET00137 | DBMET01477 | |
| 0.065 | 0.139 | 0.205 | 5 Hydroxytryptamine 3A agonist | 0.126 0.051 DBMET01477 0.205 0.014 DBMET00137 | DBMET00137 | |
| 0.1 | 0.174 | 0.275 | Pyruvate kinase inhibitor | 0.197 0.082 DBMET01476 0.275 0.054 DBMET01477 0.138 0.126 DBMET00137 | DBMET01477 | |
| 0.049 | 0.123 | 0.069 | Adenosine A3 receptor antagonist | 0.069 0.06 DBMET01477 | DBMET01477 | |
| 0.012 | 0.087 | 0.042 | Nicotinic alpha3beta4 receptor agonist | 0.042 0.009 DBMET00137 | DBMET00137 | |
| 0.14 | 0.216 | 0.198 | Thyroid hormone beta antagonist | 0.198 0.155 DBMET01477 | DBMET01477 | |
| 0.013 | 0.088 | 0.088 | Protocollagen prolyl hydroxylase inhibitor | 0.088 0.004 DBMET01477 | DBMET01477 | |
| 0.036 | 0.113 | 0.078 | Prostaglandin-E synthase inhibitor | 0.078 0.04 DBMET01477 | DBMET01477 | |
| 0.025 | 0.103 | 0.1 | Protein 50S ribosomal subunit inhibitor | 0.1 0.013 DBMET01476 | DBMET01476 | |
| 0.025 | 0.103 | 0.044 | Glutamate (mGluR5) agonist | 0.044 0.034 DBMET00137 | DBMET00137 | |
| 0.041 | 0.122 | 0.065 | Aryl hydrocarbon receptor antagonist | 0.065 0.044 DBMET00137 | DBMET00137 | |
| 0.019 | 0.102 | 0.061 | Aminopeptidase N inhibitor | 0.061 0.024 DBMET01477 | DBMET01477 | |
| 0.013 | 0.099 | 0.032 | Liver X receptor alpha antagonist | 0.032 0.016 DBMET01477 | DBMET01477 | |
| 0.032 | 0.118 | 0.052 | Glucose-6-phosphate translocase inhibitor | 0.052 0.035 DBMET01477 | DBMET01477 | |
| 0.009 | 0.095 | 0.13 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.13 0.005 DBMET01477 | DBMET01477 | |
| 0.01 | 0.098 | 0.149 | Cholecystokinin antagonist | 0.149 0.005 DBMET01477 | DBMET01477 | |
| 0.024 | 0.113 | 0.06 | Aggrecanase 1 inhibitor | 0.06 0.009 DBMET01477 | DBMET01477 | |
| 0.023 | 0.116 | 0.046 | Potassium channel Kv1.1 blocker | 0.046 0.016 DBMET00137 | DBMET00137 | |
| 0.045 | 0.139 | 0.065 | Histone deacetylase SIRT3 inhibitor | 0.065 0.037 DBMET00137 | DBMET00137 | |
| 0.05 | 0.148 | 0.116 | Antineoplastic alkaloid | 0.116 0.039 DBMET01477 | DBMET01477 | |
| 0.161 | 0.259 | 0.258 | Antiobesity | 0.258 0.149 DBMET01477 | DBMET01477 | |
| 0.09 | 0.189 | 0.125 | Cyclin-dependent kinase 8 inhibitor | 0.125 0.11 DBMET00137 | DBMET00137 | |
| 0.009 | 0.11 | 0.095 | AMPA 2 receptor antagonist | 0.095 0.005 DBMET01477 | DBMET01477 | |
| 0.01 | 0.113 | 0.037 | Urotensin II agonist | 0.037 0.01 DBMET01477 | DBMET01477 | |
| 0.021 | 0.127 | 0.051 | Collagenase inhibitor | 0.051 0.031 DBMET01477 | DBMET01477 | |
| 0.01 | 0.116 | 0.022 | Tryptophan hydroxylase 1 inhibitor | 0.022 0.005 DBMET01477 | DBMET01477 | |
| 0.033 | 0.14 | 0.068 | Transcription factor AP-1 inhibitor | 0.068 0.033 DBMET01477 | DBMET01477 | |
| 0.005 | 0.114 | 0.091 | Cholecystokinin B antagonist | 0.091 0.005 DBMET01477 | DBMET01477 | |
| 0.024 | 0.135 | 0.084 | NMDA 2 receptor antagonist | 0.084 0.041 DBMET01477 | DBMET01477 | |
| 0.005 | 0.118 | 0.018 | Alpha 2a adrenoreceptor agonist | 0.018 0.011 DBMET00137 | DBMET00137 | |
| 0.01 | 0.123 | 0.045 | Trypsin I inhibitor | 0.045 0.014 DBMET01476 | DBMET01476 | |
| 0.011 | 0.125 | 0.04 | AMPA receptor agonist | 0.04 0.018 DBMET01477 | DBMET01477 | |
| 0.011 | 0.128 | 0.032 | Liver X receptor antagonist | 0.032 0.02 DBMET01477 | DBMET01477 | |
| 0.102 | 0.224 | 0.15 | Focal adhesion kinase 2 inhibitor | 0.15 0.131 DBMET00137 | DBMET00137 | |
| 0.05 | 0.172 | 0.095 | Topoisomerase II inhibitor | 0.095 0.092 DBMET01477 | DBMET01477 | |
| 0.028 | 0.153 | 0.061 | CXC chemokine 1 receptor antagonist | 0.061 0.021 DBMET01477 | DBMET01477 | |
| 0.034 | 0.165 | 0.057 | Cathepsin E inhibitor | 0.057 0.044 DBMET01477 | DBMET01477 | |
| 0.062 | 0.193 | 0.106 | T cell inhibitor | 0.106 0.02 DBMET01477 | DBMET01477 | |
| 0.009 | 0.141 | 0.041 | Potassium channel small-conductance Ca-activated activator | 0.041 0.015 DBMET00137 | DBMET00137 | |
| 0.03 | 0.163 | 0.054 | 5 Hydroxytryptamine 7 agonist | 0.054 0.043 DBMET00137 | DBMET00137 | |
| 0.005 | 0.138 | 0.112 | Cholecystokinin A antagonist | 0.112 0.007 DBMET01477 | DBMET01477 | |
| 0.006 | 0.139 | 0.039 | Cholecystokinin A agonist | 0.039 0.005 DBMET01477 | DBMET01477 | |
| 0.058 | 0.196 | 0.179 | Nav1.4 sodium channel blocker | 0.179 0.024 DBMET01477 | DBMET01477 | |
| 0.023 | 0.169 | 0.047 | Purinergic P2X4 antagonist | 0.047 0.03 DBMET00137 | DBMET00137 | |
| 0.007 | 0.154 | 0.022 | Imidazoline I1 receptor antagonist | 0.022 0.013 DBMET00137 | DBMET00137 | |
| 0.019 | 0.178 | 0.074 | Plasmin inhibitor | 0.074 0.024 DBMET01476 | DBMET01476 | |
| 0.065 | 0.229 | 0.179 | Histone deacetylase SIRT1 inhibitor | 0.179 0.04 DBMET01477 | DBMET01477 | |
| 0.057 | 0.223 | 0.219 | 3C-Like protease (SARS coronavirus) inhibitor | 0.219 0.004 DBMET01476 | DBMET01476 | |
| 0.012 | 0.181 | 0.041 | Carbonic anhydrase I stimulant | 0.041 0.023 DBMET01477 | DBMET01477 | |
| 0.027 | 0.196 | 0.064 | Carbonic anhydrase II stimulant | 0.064 0.019 DBMET01477 | DBMET01477 | |
| 0.01 | 0.183 | 0.027 | 5 Hydroxytryptamine 6 agonist | 0.027 0.023 DBMET00137 | DBMET00137 | |
| 0.027 | 0.201 | 0.124 | Cathepsin B inhibitor | 0.124 0.01 DBMET01476 | DBMET01476 | |
| 0.1 | 0.275 | 0.257 | 5 Hydroxytryptamine 1E antagonist | 0.186 0.147 DBMET01477 0.257 0.067 DBMET00137 | DBMET00137 | |
| 0.048 | 0.228 | 0.13 | Cyclooxygenase 1 inhibitor | 0.13 0.071 DBMET01477 | DBMET01477 | |
| 0.01 | 0.195 | 0.037 | Histone deacetylase 11 inhibitor | 0.037 0.019 DBMET01476 | DBMET01476 | |
| 0.01 | 0.195 | 0.037 | Histone deacetylase class IV inhibitor | 0.037 0.019 DBMET01476 | DBMET01476 | |
| 0.134 | 0.325 | 0.354 | Caspase 3 stimulant | 0.354 0.058 DBMET01476 0.288 0.085 DBMET01477 | DBMET01476 | |
| 0.07 | 0.261 | 0.263 | Dual specificity phosphatase inhibitor | 0.263 0.035 DBMET01477 | DBMET01477 | |
| 0.058 | 0.25 | 0.161 | Aryl hydrocarbon receptor agonist | 0.161 0.127 DBMET00137 | DBMET00137 | |
| 0.006 | 0.2 | 0.037 | Histone deacetylase 10 inhibitor | 0.037 0.017 DBMET01476 | DBMET01476 | |
| 0.044 | 0.246 | 0.158 | Histone deacetylase class III inhibitor | 0.158 0.038 DBMET01477 | DBMET01477 | |
| 0.035 | 0.24 | 0.086 | Trypsin inhibitor | 0.086 0.024 DBMET01476 | DBMET01476 | |
| 0.019 | 0.246 | 0.047 | Human rhinovirus A protease inhibitor | 0.047 0.046 DBMET01476 | DBMET01476 | |
| 0.005 | 0.24 | 0.142 | Calpain 1 inhibitor | 0.142 0.003 DBMET01476 | DBMET01476 | |
| 0.033 | 0.287 | 0.166 | M17 leucyl aminopeptidase inhibitor | 0.166 0.047 DBMET01477 | DBMET01477 | |
| 0.048 | 0.312 | 0.231 | Dual specificity phosphatase 3 inhibitor | 0.231 0.047 DBMET01477 | DBMET01477 | |
| 0.046 | 0.322 | 0.116 | Interleukin 1 antagonist | 0.116 0.095 DBMET01477 | DBMET01477 | |
| 0.042 | 0.318 | 0.143 | Mcl-1 antagonist | 0.143 0.097 DBMET01477 | DBMET01477 | |
| 0.012 | 0.292 | 0.072 | Plasminogen activator inhibitor | 0.072 0.031 DBMET01476 | DBMET01476 | |
| 0.018 | 0.332 | 0.087 | Thrombin inhibitor | 0.087 0.035 DBMET01476 | DBMET01476 | |
| 0.003 | 0.33 | 0.024 | 3C-Like protease (MERS coronavirus) inhibitor | 0.024 0.003 DBMET01476 | DBMET01476 | |
| 0.022 | 0.374 | 0.067 | Orexin receptor 1 antagonist | 0.067 0.066 DBMET00137 | DBMET00137 | |
| 0.016 | 0.57 | 0.094 | Factor XII inhibitor | 0.094 0.044 DBMET01476 | DBMET01476 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |